Raw JSON
{'hasResults': True, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D011471', 'term': 'Prostatic Neoplasms'}], 'ancestors': [{'id': 'D005834', 'term': 'Genital Neoplasms, Male'}, {'id': 'D014565', 'term': 'Urogenital Neoplasms'}, {'id': 'D009371', 'term': 'Neoplasms by Site'}, {'id': 'D009369', 'term': 'Neoplasms'}, {'id': 'D005832', 'term': 'Genital Diseases, Male'}, {'id': 'D000091662', 'term': 'Genital Diseases'}, {'id': 'D000091642', 'term': 'Urogenital Diseases'}, {'id': 'D011469', 'term': 'Prostatic Diseases'}, {'id': 'D052801', 'term': 'Male Urogenital Diseases'}]}}, 'resultsSection': {'moreInfoModule': {'pointOfContact': {'email': 'DK0-Disclosure@ferring.com', 'title': 'Clinical Development Support', 'organization': 'Ferring Pharmaceuticals'}, 'certainAgreement': {'otherDetails': 'The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.', 'restrictionType': 'OTHER', 'piSponsorEmployee': False, 'restrictiveAgreement': True}}, 'adverseEventsModule': {'timeFrame': 'From baseline upto 5 years (every 3 months from the first 2 years of the study; every 6 months for the last 3 years of the study)', 'description': 'An AE was defined as any untoward medical occurrence in a subject participating in a clinical investigation who received a pharmaceutical product.\n\nThe safety analysis set comprised of all subjects treated with at least one dose of medicinal product. The data was restricted to main treatment period (from signing of informed consent and administration of first dose until loss to follow-up, change/discontinuation in ADT, or end-of-study visit, whatever came first).', 'eventGroups': [{'id': 'EG000', 'title': 'FIRMAGON', 'description': 'FIRMAGON (Degarelix, a GnRH antagonist) was prescribed in accordance with the approved label', 'otherNumAtRisk': 1000, 'deathsNumAtRisk': 1000, 'otherNumAffected': 294, 'seriousNumAtRisk': 1000, 'deathsNumAffected': 141, 'seriousNumAffected': 236}, {'id': 'EG001', 'title': 'GnRH Agonist', 'description': 'Any GnRH agonist prescribed in accordance with the approved labels', 'otherNumAtRisk': 493, 'deathsNumAtRisk': 493, 'otherNumAffected': 110, 'seriousNumAtRisk': 493, 'deathsNumAffected': 72, 'seriousNumAffected': 144}], 'otherEvents': [{'term': 'Injection site pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 226, 'numAffected': 100}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 2, 'numAffected': 2}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Prostatic specific antigen increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 90, 'numAffected': 80}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 29, 'numAffected': 26}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Hot flush', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 172, 'numAffected': 166}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 92, 'numAffected': 88}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}], 'seriousEvents': [{'term': 'Anaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 9, 'numAffected': 6}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 13, 'numAffected': 10}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Thrombocytopenia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Neutropenia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Immune thrombocytopenic purpura', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Lymphadenopathy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Cardiac failure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 8, 'numAffected': 8}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 5, 'numAffected': 5}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Myocardial infarction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 9, 'numAffected': 9}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Cardiac arrest', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 5, 'numAffected': 5}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Cardiopulmonary failure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 3, 'numAffected': 3}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Atrial fibrillation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 4, 'numAffected': 4}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Coronary artery disease', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 2, 'numAffected': 2}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Myocardial ischemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 3, 'numAffected': 3}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Acute myocardial infarction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Acute coronary syndrome', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 2, 'numAffected': 2}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Cardiac failure congestive', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Left ventricular hypertrophy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Tachycardia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Angina pectoris', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Angina unstable', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Arrhythmia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Cardiac disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Coronary artery insufficiency', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Coronary artery occlusion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Hypertensive heart disease', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Mitral valve incompetence', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Palpitations', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Subventricular tachycardia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Ventricular tachycardia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Vertigo', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Ear and labyrinth disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Vestibular disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Ear and labyrinth disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Cataract', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Eye disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Diarrhoea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Vomiting', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Intestinal obstruction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Large intestine polyp', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Nausea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Abdominal pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Constipation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Rectal haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Abdominal discomfort', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Abdominal pain upper', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': "Crohn's disease", 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 2, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Diverticulum intestinal haemorrhagic', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Duodenal ulcer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Gastrooesophageal reflux disease', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Haematochezia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Incarcerated umbilical hernia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Inguinal hernia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Intestinal perforation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Melaena', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Pancreatitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Pancreatitis acute', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Proctalgia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Rectal obstruction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Small intestinal haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Umbilical hernia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Disease progression', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 26, 'numAffected': 25}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 12, 'numAffected': 12}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Death', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 12, 'numAffected': 12}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 6, 'numAffected': 6}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'General physical health deterioration', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 10, 'numAffected': 10}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 5, 'numAffected': 5}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Multiple organ dysfunction syndrome', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 3, 'numAffected': 3}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Asthenia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 3, 'numAffected': 3}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Chest pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 3, 'numAffected': 3}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Pyrexia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 5, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Fatigue', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Oedema peripheral', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Sudden death', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 2, 'numAffected': 2}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Injection site pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Bile duct stone', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Biliary tract disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Hepatic cyst', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Hepatic failure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Pneumonia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 5, 'numAffected': 5}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 10, 'numAffected': 9}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Urinary tract infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 5, 'numAffected': 5}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 8, 'numAffected': 6}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Sepsis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 6, 'numAffected': 6}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 3, 'numAffected': 3}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Gangrene', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Pyelonephritis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Urosepsis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Appendicitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Catheter site infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Cellulitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Echinococciasis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Erysipelas', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Herpes zoster', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Injection site abscess', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Injection site infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Kidney infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Lower respiratory tract infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Lung infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Oral fungal infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Peritoneal abscess', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Periumbilical abscess', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Pharyngitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Postoperative wound infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Respiratory tract infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Septic shock', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Severe acute respiratory syndrome', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Skin infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Staphylococcal infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Vestibular neuronitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Wound infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Femur fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 4, 'numAffected': 4}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Fall', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 2, 'numAffected': 2}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Hip fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Femoral neck fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Road traffic accident', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Urinary retention postoperative', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Abdominal injury', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Ankle fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Cervical vertebral fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Concussion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Cystitis radiation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Head Injury', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Humerus fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Laceration', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Post procedural haematuria', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Radiation proctitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Radius fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Rib fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Skull fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Spinal fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Subdural haematoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Ulna fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Wound', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Prostatic specific antigen increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 5, 'numAffected': 5}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Blood creatinine increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Haemoglobin decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Blood alkaline phosphatase increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Blood urea increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Haematocrit dereased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Platelet count decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Weight decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Dehydration', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 2, 'numAffected': 2}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Decreased appetite', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Hyperglycemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Hyperkalaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Hypocalcaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Hypoglycaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Lactic acidosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Malnutrition', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Obesity', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Type 2 diabetes mellitus', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Pathological fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 2, 'numAffected': 2}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Back pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Bone pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Osteoarthritis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Osteonecrosis of jaw', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 5, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Arthritis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Osteoporotic fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 2, 'numAffected': 2}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Flank pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Intervertebral disc protrusion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Musculoskeletal pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Osteonecrosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Pain in extremity', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Synovial cyst', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Vertebral lesion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Prostate cancer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 41, 'numAffected': 40}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 11, 'numAffected': 10}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Metastases to bone', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 6, 'numAffected': 6}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 2, 'numAffected': 2}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Cancer pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 2, 'numAffected': 2}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Prostate cancer metastatic', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 3, 'numAffected': 3}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Lung neoplasm malignant', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Bladder cancer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Bladder neoplasm', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Colon cancer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Metastases to liver', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 2, 'numAffected': 2}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Colon neoplasm', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 2, 'numAffected': 2}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Colorectal cancer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Metastases to central nervous system', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Neoplasm progression', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Pancreatic carcinoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Basal cell carcinoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Benign neoplasm of ureter', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Bladder adenocarcinoma stage unspecified', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Bladder cancer recurrent', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Bladder transitional cell carcinoma recurrent', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Bronchial carcinoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Chronic myeloid leukaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Colon cancer metastatic', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Gastric cancer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Gastrointestinal cancer metastatic', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Glioblastoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Hepatic neoplasm', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Hormone-refractory prostate cancer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Intestinal adenocarcinoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Laryngeal cancer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Lymphoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 2, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Malignant neoplasm of renal pelvis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Malignant neoplasm progression', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Metastases to bladder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Metastases to spine', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Neoplasm of thymus', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Non-small cell lung cancer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Rectal cancer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Renal cell carcinoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Retroperitoneal neoplasm', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Squamous cell carcinoma of lung', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Squamous cell carcinoma of the oral cavity', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Transitional cell carcinoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Cerebrovascular accident', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 5, 'numAffected': 5}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 2, 'numAffected': 2}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Syncope', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 4, 'numAffected': 4}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Spinal cord compression', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Transient ischaemic attack', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 2, 'numAffected': 2}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Dizziness', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Hypoaesthesis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Anterograde amnesia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Balance disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Cerebral arteriosclerosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Cerebral haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Cerebral ischaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Cognitive disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Dementia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Embolic stroke', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Encephalopathy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Haemorrhage intracranial', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Haemorrhagic stroke', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Headache', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Hemiplegia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Ischemic stroke', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Loss of consciosness', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Mobility decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Orthostatic intolerance', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Peripheral sensorimotor neuropathy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Presyncope', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Subarachnoid haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Vertebrobasilar insufficiency', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Confusional state', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Depression', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 3, 'numAffected': 2}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Anxiety', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Completed suicide', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Delirium', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 2, 'numAffected': 2}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Anxiety disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Hallucination', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Urinary retention', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 12, 'numAffected': 12}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 6, 'numAffected': 6}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Acute kidney injury', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 8, 'numAffected': 8}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Hydronephrosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 8, 'numAffected': 8}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Renal failure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 6, 'numAffected': 6}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 2, 'numAffected': 2}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Haematuria', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 5, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Urinary incontinence', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Dysuria', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Nephrolithiasis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 2, 'numAffected': 2}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Ureteric dilatation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 2, 'numAffected': 2}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Urethral stenosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Anuria', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Bladder neck obstruction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 2, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Calculus bladder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 2, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Incontinence', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Kidney enlargement', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Lower urinary tract symptoms', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Nocturia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Pollakiuria', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Renal impairment', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Stress urinary incontinence', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Urethral disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Urinary tract obstruction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Vesical fistula', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Benign prostatic hyperplasia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Prostatic obstruction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Rectoprostatic fistula', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Testicular pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Dyapnoea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 9, 'numAffected': 7}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 3, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Pulmonary embolism', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 5, 'numAffected': 5}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Chronic obstructive pulmonary disease', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 4, 'numAffected': 4}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Lung disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Respiratory failure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Pleural effusion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 8, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Pulmonary oedema', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 2, 'numAffected': 2}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Acute pulmonary oedema', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Aspiration', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Epistaxis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Haemothorax', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Laryngeal oedema', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Lung consolidation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Obstructive airways disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Pneumonia aspiration', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Pneumothorax', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Respiratory arrest', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Thoracic haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Skin ulcer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Hyperhidrosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Stevens-johnson syndrome', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Urticaria', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Eye prosthesis insertion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Surgical and medical procedures', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Ileostomy closure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Surgical and medical procedures', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Medical induction of coma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Surgical and medical procedures', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Nephrostomy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Surgical and medical procedures', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Spinal operation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Surgical and medical procedures', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Circulatory collapse', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Deep vein thrombosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Hypertension', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Hypotension', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Thrombosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Aortic aneurysm', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Aortic aneurysm rupture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Aortic stenosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Dry gangrene', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Lymphoedema', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Peripheral arterial occlusive disease', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Peripheral artery occlusion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Peripheral ischaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Shock haemorrhagic', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Thrombophlebitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 2, 'numAffected': 1}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}, {'term': 'Iron deficiency anaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1000, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 493, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (19.0)'}], 'frequencyThreshold': '5'}, 'outcomeMeasuresModule': {'outcomeMeasures': [{'type': 'PRIMARY', 'title': 'Incidence Rate of Adverse Events of Special Interest (AESI): Cardiovascular Events', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1000', 'groupId': 'OG000'}, {'value': '493', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'FIRMAGON', 'description': 'FIRMAGON (Degarelix, a GnRH antagonist) was prescribed in accordance with the approved label'}, {'id': 'OG001', 'title': 'GnRH Agonist', 'description': 'Any GnRH agonist prescribed in accordance with the approved labels'}], 'classes': [{'categories': [{'measurements': [{'value': '3.8', 'groupId': 'OG000'}, {'value': '4.5', 'groupId': 'OG001'}]}]}], 'analyses': [{'pValue': '0.4007', 'groupIds': ['OG000', 'OG001'], 'paramType': 'IRR', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '0.829', 'ciLowerLimit': '0.536', 'ciUpperLimit': '1.283', 'pValueComment': 'Poisson-mixture regression was used to model the influence of age, stage of disease, and relevant medical history along with the treatment group effect on the number of events adjusted for individual study exposures measured in 100 PYE.', 'estimateComment': 'IRR for treatment with the lower 95% confidence limit \\>1 suggest increased risk of AESI; upper confidence limit \\<1 suggest decreased risk of AESI with the use of FIRMAGON. The limit including 1 suggests no difference b/w treatment groups.', 'groupDescription': 'The IRs were estimated using a Poisson-mixture regression model.', 'statisticalMethod': 'Wald test', 'nonInferiorityType': 'OTHER', 'statisticalComment': 'The IRs for each treatment arm with 95% confidence interval (CI), and incidence rate ratio (IRRs) with 95% CI and p-values were based on Wald test.'}], 'paramType': 'NUMBER', 'timeFrame': 'From baseline upto 5 years (every 3 months from the first 2 years of the study; every 6 months for the last 3 years of the study)', 'description': 'The incidence rate (IR) expressed as number of events per 100 patient-years of exposure (PYE).', 'unitOfMeasure': 'Events per 100 PYE', 'reportingStatus': 'POSTED', 'populationDescription': 'The safety analysis set comprised of all subjects treated with at least one dose of medicinal product. The data was restricted to main treatment period (from signing of informed consent and administration of first dose until loss to follow-up, change/discontinuation in ADT, or end-of-study visit, whatever came first).'}, {'type': 'PRIMARY', 'title': 'Incidence Rate of AESI: Decreased Bone Density', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1000', 'groupId': 'OG000'}, {'value': '493', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'FIRMAGON', 'description': 'FIRMAGON (Degarelix, a GnRH antagonist) was prescribed in accordance with the approved label'}, {'id': 'OG001', 'title': 'GnRH Agonist', 'description': 'Any GnRH prescribed in accordance with the approved labels'}], 'classes': [{'title': 'Osteoporosis or Osteopenia', 'categories': [{'measurements': [{'value': '1.1', 'groupId': 'OG000'}, {'value': '1.4', 'groupId': 'OG001'}]}]}, {'title': 'Bone fracture', 'categories': [{'measurements': [{'value': '0.3', 'groupId': 'OG000'}, {'value': '0.1', 'groupId': 'OG001'}]}]}], 'analyses': [{'pValue': '0.6710', 'groupIds': ['OG000', 'OG001'], 'paramType': 'IRR', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '0.874', 'ciLowerLimit': '0.470', 'ciUpperLimit': '1.626', 'pValueComment': 'Poisson-mixture regression was used to model the influence of age, stage of disease, and relevant medical history along with the treatment group effect on the number of events adjusted for individual study exposures measured in 100 PYE.', 'estimateComment': 'IRR for treatment with the lower 95% confidence limit \\>1 suggest increased risk of AESI; upper confidence limit \\<1 suggest decreased risk of AESI with the use of FIRMAGON. The limit including 1 suggests no difference b/w treatment groups.', 'groupDescription': 'For osteoporosis and osteopenia events. The IRs were estimated using Poisson-mixture regression model.', 'statisticalMethod': 'Wald test', 'nonInferiorityType': 'OTHER', 'statisticalComment': 'The IRs for each treatment arm with 95% CI, and IRRs with 95% CI and p-values were based on Wald test.'}, {'pValue': '0.4544', 'groupIds': ['OG000', 'OG001'], 'paramType': 'IRR', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '1.857', 'ciLowerLimit': '0.367', 'ciUpperLimit': '9.403', 'pValueComment': 'Poisson-mixture regression was used to model the influence of age, stage of disease, and relevant medical history along with the treatment group effect on the number of events adjusted for individual study exposures measured in 100 PYE.', 'estimateComment': 'IRR for treatment with the lower 95% confidence limit \\>1 suggest increased risk of AESI; upper confidence limit \\<1 suggest decreased risk of AESI with the use of FIRMAGON. The limit including 1 suggests no difference b/w treatment groups.', 'groupDescription': 'For bone fracture events. The IRs were estimated using Poisson-mixture regression model.', 'statisticalMethod': 'Wald test', 'nonInferiorityType': 'OTHER', 'statisticalComment': 'The IRs for each treatment arm with 95% CI, and IRRs with 95% CI and p-values were based on Wald test.'}], 'paramType': 'NUMBER', 'timeFrame': 'From baseline upto 5 years (every 3 months from the first 2 years of the study; every 6 months for the last 3 years of the study)', 'description': 'IR of osteoporosis or osteopenia and bone fracture events are presented. The IR is expressed as number of events per 100 PYE.', 'unitOfMeasure': 'Events per 100 PYE', 'reportingStatus': 'POSTED', 'populationDescription': 'The safety analysis set comprised of all subjects treated with at least one dose of medicinal product. The data was restricted to main treatment period (from signing of informed consent and administration of first dose until loss to follow-up, change/discontinuation in ADT, or end-of-study visit, whatever came first).'}, {'type': 'PRIMARY', 'title': 'Incidence Rate of AESI: Glucose Intolerance or Type 2 Diabetes Mellitus (T2DM)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1000', 'groupId': 'OG000'}, {'value': '493', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'FIRMAGON', 'description': 'FIRMAGON (Degarelix, a GnRH antagonist) was prescribed in accordance with the approved label'}, {'id': 'OG001', 'title': 'GnRH Agonist', 'description': 'Any GnRH prescribed in accordance with the approved labels'}], 'classes': [{'title': 'Glucose intolerance', 'categories': [{'measurements': [{'value': '15.3', 'groupId': 'OG000'}, {'value': '13.2', 'groupId': 'OG001'}]}]}, {'title': 'T2DM', 'categories': [{'measurements': [{'value': '1.8', 'groupId': 'OG000'}, {'value': '0.7', 'groupId': 'OG001'}]}]}], 'analyses': [{'pValue': '0.2529', 'groupIds': ['OG000', 'OG001'], 'paramType': 'IRR', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '1.193', 'ciLowerLimit': '0.882', 'ciUpperLimit': '1.613', 'pValueComment': 'Poisson mixture regression was used to model the influence of age, stage of disease, and history of diabetes mellitus along with the treatment group effect on the number of events adjusted for individual study exposures measured in 100 PYE.', 'estimateComment': 'IRR for treatment with the lower 95% confidence limit \\>1 suggest increased risk of AESI; upper confidence limit \\<1 suggest decreased risk of AESI with the use of FIRMAGON. The limit including 1 suggests no difference b/w treatment groups.', 'groupDescription': 'For glucose intolerance. The IRs were estimated using Poisson-mixture regression model.', 'statisticalMethod': 'Wald test', 'nonInferiorityType': 'OTHER', 'statisticalComment': 'The IRs for each treatment arm with 95% CI, and IRRs with 95% CI and p-values were based on Wald test.'}, {'pValue': '0.0208', 'groupIds': ['OG000', 'OG001'], 'paramType': 'IRR', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '2.623', 'ciLowerLimit': '1.158', 'ciUpperLimit': '5.944', 'pValueComment': 'Poisson-mixture regression is used to model the influence of age, stage of disease, and relevant medical history along with the treatment group effect on the number of events adjusted for individual trial exposures measured in 100 PYE.', 'estimateComment': 'IRR for treatment with the lower 95% confidence limit \\>1 suggest increased risk of AESI; upper confidence limit \\<1 suggest decreased risk of AESI with the use of FIRMAGON. The limit including 1 suggests no difference b/w treatment groups.', 'groupDescription': 'For T2DM. The IRs were estimated using Poisson-mixture regression model.', 'statisticalMethod': 'Wald test', 'nonInferiorityType': 'OTHER', 'statisticalComment': 'The IRs for each treatment arm with 95% CI, and IRRs with 95% CI and p-values were based on Wald test.'}], 'paramType': 'NUMBER', 'timeFrame': 'From baseline upto 5 years (every 3 months from the first 2 years of the study; every 6 months for the last 3 years of the study)', 'description': 'IR of new onset or exacerbation of glucose intolerance or T2DM were presented. The IR expressed as number of events per 100 PYE.\n\nGlucose intolerance events were defined as events of levels of fasting glucose of 6.1 to 6.9 mmol/L', 'unitOfMeasure': 'Events per 100 PYE', 'reportingStatus': 'POSTED', 'populationDescription': 'The safety analysis set comprised of all subjects treated with at least one dose of medicinal product. The data was restricted to main treatment period (from signing of informed consent and administration of first dose until loss to follow-up, change/discontinuation in ADT, or end-of-study visit, whatever came first).'}, {'type': 'PRIMARY', 'title': 'Change in Hepatic Enzymes', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1000', 'groupId': 'OG000'}, {'value': '493', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'FIRMAGON', 'description': 'FIRMAGON (Degarelix, a GnRH antagonist) was prescribed in accordance with the approved label'}, {'id': 'OG001', 'title': 'GnRH Agonist', 'description': 'Any GnRH Agonist prescribed in accordance with the approved labels'}], 'classes': [{'title': 'ALT (Visit 2, Month 3)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '302', 'groupId': 'OG000'}, {'value': '120', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.1', 'groupId': 'OG000', 'lowerLimit': '-70', 'upperLimit': '63'}, {'value': '0.1', 'groupId': 'OG001', 'lowerLimit': '-19', 'upperLimit': '82'}]}]}, {'title': 'ALT (Visit 3, Month 6)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '272', 'groupId': 'OG000'}, {'value': '115', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.1', 'groupId': 'OG000', 'lowerLimit': '-65', 'upperLimit': '174'}, {'value': '0.1', 'groupId': 'OG001', 'lowerLimit': '-41', 'upperLimit': '125'}]}]}, {'title': 'ALT (Visit 4, Month 9)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '243', 'groupId': 'OG000'}, {'value': '109', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-66', 'upperLimit': '55'}, {'value': '0.0', 'groupId': 'OG001', 'lowerLimit': '-22', 'upperLimit': '54'}]}]}, {'title': 'ALT (Visit 5, Month 12)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '212', 'groupId': 'OG000'}, {'value': '109', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-63', 'upperLimit': '57'}, {'value': '0.0', 'groupId': 'OG001', 'lowerLimit': '-38', 'upperLimit': '49'}]}]}, {'title': 'ALT (Visit 6, Month 15)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '195', 'groupId': 'OG000'}, {'value': '107', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-0.1', 'groupId': 'OG000', 'lowerLimit': '-69', 'upperLimit': '30'}, {'value': '0.0', 'groupId': 'OG001', 'lowerLimit': '-44', 'upperLimit': '37'}]}]}, {'title': 'ALT (Visit 7, Month 18)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '183', 'groupId': 'OG000'}, {'value': '98', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-0.1', 'groupId': 'OG000', 'lowerLimit': '-68', 'upperLimit': '41'}, {'value': '0.1', 'groupId': 'OG001', 'lowerLimit': '-26', 'upperLimit': '77'}]}]}, {'title': 'ALT (Visit 8, Month 21)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '170', 'groupId': 'OG000'}, {'value': '99', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-0.1', 'groupId': 'OG000', 'lowerLimit': '-70', 'upperLimit': '204'}, {'value': '0.1', 'groupId': 'OG001', 'lowerLimit': '-25', 'upperLimit': '49'}]}]}, {'title': 'ALT (Visit 9, Month 24)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '155', 'groupId': 'OG000'}, {'value': '97', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-0.1', 'groupId': 'OG000', 'lowerLimit': '-65', 'upperLimit': '332'}, {'value': '0.0', 'groupId': 'OG001', 'lowerLimit': '-24', 'upperLimit': '20'}]}]}, {'title': 'ALT (Visit 10, Month 30)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '151', 'groupId': 'OG000'}, {'value': '89', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-0.1', 'groupId': 'OG000', 'lowerLimit': '-80', 'upperLimit': '28'}, {'value': '0.0', 'groupId': 'OG001', 'lowerLimit': '-23', 'upperLimit': '26'}]}]}, {'title': 'ALT (Visit 11, Month 36)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '134', 'groupId': 'OG000'}, {'value': '89', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-0.1', 'groupId': 'OG000', 'lowerLimit': '-50', 'upperLimit': '317'}, {'value': '0.0', 'groupId': 'OG001', 'lowerLimit': '-16', 'upperLimit': '90'}]}]}, {'title': 'ALT (Visit 12, Month 42)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '123', 'groupId': 'OG000'}, {'value': '73', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-0.1', 'groupId': 'OG000', 'lowerLimit': '-35', 'upperLimit': '31'}, {'value': '0.0', 'groupId': 'OG001', 'lowerLimit': '-44', 'upperLimit': '33'}]}]}, {'title': 'ALT (Visit 13, Month 48)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '95', 'groupId': 'OG000'}, {'value': '66', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-1.0', 'groupId': 'OG000', 'lowerLimit': '-36', 'upperLimit': '97'}, {'value': '0.0', 'groupId': 'OG001', 'lowerLimit': '-45', 'upperLimit': '28'}]}]}, {'title': 'ALT (Visit 14, Month 54)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '79', 'groupId': 'OG000'}, {'value': '56', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-1.0', 'groupId': 'OG000', 'lowerLimit': '-53', 'upperLimit': '32'}, {'value': '-0.1', 'groupId': 'OG001', 'lowerLimit': '-32', 'upperLimit': '13'}]}]}, {'title': 'ALT (Visit 15, end of trial [EOT], Month 60)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '58', 'groupId': 'OG000'}, {'value': '42', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-0.2', 'groupId': 'OG000', 'lowerLimit': '-30', 'upperLimit': '33'}, {'value': '0.0', 'groupId': 'OG001', 'lowerLimit': '-16', 'upperLimit': '16'}]}]}, {'title': 'ALP (Visit 2, Month 3)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '278', 'groupId': 'OG000'}, {'value': '131', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-661', 'upperLimit': '738'}, {'value': '-0.1', 'groupId': 'OG001', 'lowerLimit': '-632', 'upperLimit': '240'}]}]}, {'title': 'ALP (Visit 3, Month 6)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '247', 'groupId': 'OG000'}, {'value': '123', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-990', 'upperLimit': '979'}, {'value': '0.0', 'groupId': 'OG001', 'lowerLimit': '-649', 'upperLimit': '135'}]}]}, {'title': 'ALP (Visit 4, Month 9)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '223', 'groupId': 'OG000'}, {'value': '116', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-1009', 'upperLimit': '1024'}, {'value': '0.1', 'groupId': 'OG001', 'lowerLimit': '-658', 'upperLimit': '225'}]}]}, {'title': 'ALP (Visit 5, Month 12)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '203', 'groupId': 'OG000'}, {'value': '111', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-1029', 'upperLimit': '614'}, {'value': '0.1', 'groupId': 'OG001', 'lowerLimit': '-661', 'upperLimit': '184'}]}]}, {'title': 'ALP (Visit 6, Month 15)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '181', 'groupId': 'OG000'}, {'value': '113', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.1', 'groupId': 'OG000', 'lowerLimit': '-1027', 'upperLimit': '957'}, {'value': '0.0', 'groupId': 'OG001', 'lowerLimit': '-225', 'upperLimit': '370'}]}]}, {'title': 'ALP (Visit 7, Month 18)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '184', 'groupId': 'OG000'}, {'value': '105', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.1', 'groupId': 'OG000', 'lowerLimit': '-1031', 'upperLimit': '475'}, {'value': '0.1', 'groupId': 'OG001', 'lowerLimit': '-217', 'upperLimit': '889'}]}]}, {'title': 'ALP (Visit 8, Month 21)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '156', 'groupId': 'OG000'}, {'value': '109', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-539', 'upperLimit': '777'}, {'value': '0.0', 'groupId': 'OG001', 'lowerLimit': '-197', 'upperLimit': '364'}]}]}, {'title': 'ALP (Visit 9, Month 24)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '148', 'groupId': 'OG000'}, {'value': '104', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.1', 'groupId': 'OG000', 'lowerLimit': '-756', 'upperLimit': '307'}, {'value': '0.1', 'groupId': 'OG001', 'lowerLimit': '-228', 'upperLimit': '446'}]}]}, {'title': 'ALP (Visit 10, Month 30)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '139', 'groupId': 'OG000'}, {'value': '96', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-540', 'upperLimit': '300'}, {'value': '0.1', 'groupId': 'OG001', 'lowerLimit': '-211', 'upperLimit': '169'}]}]}, {'title': 'ALP (Visit 11, Month 36)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '122', 'groupId': 'OG000'}, {'value': '96', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-0.3', 'groupId': 'OG000', 'lowerLimit': '-764', 'upperLimit': '748'}, {'value': '0.1', 'groupId': 'OG001', 'lowerLimit': '-185', 'upperLimit': '386'}]}]}, {'title': 'ALP (Visit 12, Month 42)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '113', 'groupId': 'OG000'}, {'value': '84', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-0.1', 'groupId': 'OG000', 'lowerLimit': '-773', 'upperLimit': '1238'}, {'value': '0.2', 'groupId': 'OG001', 'lowerLimit': '-182', 'upperLimit': '235'}]}]}, {'title': 'ALP (Visit 13, Month 48)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '84', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-0.1', 'groupId': 'OG000', 'lowerLimit': '-785', 'upperLimit': '657'}, {'value': '0.2', 'groupId': 'OG001', 'lowerLimit': '-204', 'upperLimit': '114'}]}]}, {'title': 'ALP (Visit 14, Month 54)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '80', 'groupId': 'OG000'}, {'value': '69', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-0.2', 'groupId': 'OG000', 'lowerLimit': '-779', 'upperLimit': '79'}, {'value': '0.3', 'groupId': 'OG001', 'lowerLimit': '-197', 'upperLimit': '104'}]}]}, {'title': 'ALP (Visit 15 [EOT], Month 60)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '57', 'groupId': 'OG000'}, {'value': '54', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-5.0', 'groupId': 'OG000', 'lowerLimit': '-756', 'upperLimit': '164'}, {'value': '0.2', 'groupId': 'OG001', 'lowerLimit': '-157', 'upperLimit': '89'}]}]}, {'title': 'AST (Visit 2, Month 6)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '290', 'groupId': 'OG000'}, {'value': '126', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.1', 'groupId': 'OG000', 'lowerLimit': '-72', 'upperLimit': '64'}, {'value': '0.0', 'groupId': 'OG001', 'lowerLimit': '-82', 'upperLimit': '49'}]}]}, {'title': 'AST (Visit 3, Month 9)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '256', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.1', 'groupId': 'OG000', 'lowerLimit': '-73', 'upperLimit': '79'}, {'value': '0.0', 'groupId': 'OG001', 'lowerLimit': '-74', 'upperLimit': '37'}]}]}, {'title': 'AST (Visit 4, Month 12)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '233', 'groupId': 'OG000'}, {'value': '113', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-68', 'upperLimit': '69'}, {'value': '0.1', 'groupId': 'OG001', 'lowerLimit': '-41', 'upperLimit': '60'}]}]}, {'title': 'AST (Visit 5, Month 15)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '202', 'groupId': 'OG000'}, {'value': '115', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-72', 'upperLimit': '44'}, {'value': '0.1', 'groupId': 'OG001', 'lowerLimit': '-77', 'upperLimit': '108'}]}]}, {'title': 'AST (Visit 6, Month 15)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '188', 'groupId': 'OG000'}, {'value': '108', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-73', 'upperLimit': '194'}, {'value': '0.1', 'groupId': 'OG001', 'lowerLimit': '-78', 'upperLimit': '54'}]}]}, {'title': 'AST (Visit 7, Month 18)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '169', 'groupId': 'OG000'}, {'value': '104', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-72', 'upperLimit': '108'}, {'value': '0.1', 'groupId': 'OG001', 'lowerLimit': '-37', 'upperLimit': '60'}]}]}, {'title': 'AST (Visit 8, Month 21)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '161', 'groupId': 'OG000'}, {'value': '103', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-73', 'upperLimit': '25'}, {'value': '0.1', 'groupId': 'OG001', 'lowerLimit': '-45', 'upperLimit': '73'}]}]}, {'title': 'AST (Visit 9, Month 24)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '143', 'groupId': 'OG000'}, {'value': '95', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-75', 'upperLimit': '68'}, {'value': '0.0', 'groupId': 'OG001', 'lowerLimit': '-43', 'upperLimit': '32'}]}]}, {'title': 'AST (Visit 10, Month 30)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '136', 'groupId': 'OG000'}, {'value': '92', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-73', 'upperLimit': '28'}, {'value': '0.0', 'groupId': 'OG001', 'lowerLimit': '-46', 'upperLimit': '665'}]}]}, {'title': 'AST (Visit 11, Month 36)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '124', 'groupId': 'OG000'}, {'value': '92', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-72', 'upperLimit': '57'}, {'value': '0.1', 'groupId': 'OG001', 'lowerLimit': '-43', 'upperLimit': '43'}]}]}, {'title': 'AST (Visit 12, Month 40)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '113', 'groupId': 'OG000'}, {'value': '76', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-70', 'upperLimit': '21'}, {'value': '0.0', 'groupId': 'OG001', 'lowerLimit': '-53', 'upperLimit': '30'}]}]}, {'title': 'AST (Visit 13, Month 48)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '90', 'groupId': 'OG000'}, {'value': '68', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-0.1', 'groupId': 'OG000', 'lowerLimit': '-70', 'upperLimit': '167'}, {'value': '0.0', 'groupId': 'OG001', 'lowerLimit': '-52', 'upperLimit': '18'}]}]}, {'title': 'AST (Visit 14, Month 54)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '73', 'groupId': 'OG000'}, {'value': '54', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-0.3', 'groupId': 'OG000', 'lowerLimit': '-68', 'upperLimit': '34'}, {'value': '0.0', 'groupId': 'OG001', 'lowerLimit': '-48', 'upperLimit': '29'}]}]}, {'title': 'AST (Visit 15 [EOT], Month 60)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '52', 'groupId': 'OG000'}, {'value': '44', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-35', 'upperLimit': '22'}, {'value': '0.0', 'groupId': 'OG001', 'lowerLimit': '-42', 'upperLimit': '15'}]}]}], 'paramType': 'MEDIAN', 'timeFrame': 'From baseline upto 5 years (every 3 months from the first 2 years of the study; every 6 months for the last 3 years of the study)', 'description': 'Change from baseline in hepatic enzyme levels (alanine aminotransferase \\[ALT\\], aspartate aminotransferase \\[AST\\], and alkaline phosphatase \\[ALP\\]) are presented.', 'unitOfMeasure': 'IU/L', 'dispersionType': 'Full Range', 'reportingStatus': 'POSTED', 'populationDescription': 'The safety analysis set comprised of all subjects treated with at least one dose of medicinal product. The data was restricted to main treatment period (from signing of informed consent and administration of first dose until loss to follow-up, change/discontinuation in ADT, or end-of-study visit, whatever came first).'}, {'type': 'PRIMARY', 'title': 'Change in Hepatic Enzymes', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1000', 'groupId': 'OG000'}, {'value': '493', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'FIRMAGON', 'description': 'FIRMAGON (Degarelix, a GnRH antagonist) was prescribed in accordance with the approved label'}, {'id': 'OG001', 'title': 'GnRH Agonist', 'description': 'Any GnRH prescribed in accordance with the approved labels'}], 'classes': [{'title': 'Visit 2, Month 3', 'denoms': [{'units': 'Participants', 'counts': [{'value': '208', 'groupId': 'OG000'}, {'value': '78', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-1.0', 'groupId': 'OG000', 'lowerLimit': '-169', 'upperLimit': '97'}, {'value': '-1.0', 'groupId': 'OG001', 'lowerLimit': '-108', 'upperLimit': '15'}]}]}, {'title': 'Visit 3, Month 6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '194', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-1.0', 'groupId': 'OG000', 'lowerLimit': '-234', 'upperLimit': '216'}, {'value': '-2.0', 'groupId': 'OG001', 'lowerLimit': '-16', 'upperLimit': '136'}]}]}, {'title': 'Visit 4, Month 9', 'denoms': [{'units': 'Participants', 'counts': [{'value': '168', 'groupId': 'OG000'}, {'value': '65', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-0.9', 'groupId': 'OG000', 'lowerLimit': '-233', 'upperLimit': '38'}, {'value': '-0.6', 'groupId': 'OG001', 'lowerLimit': '-18', 'upperLimit': '93'}]}]}, {'title': 'Visit 5, Month 12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '152', 'groupId': 'OG000'}, {'value': '64', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-1.3', 'groupId': 'OG000', 'lowerLimit': '-98', 'upperLimit': '113'}, {'value': '-0.6', 'groupId': 'OG001', 'lowerLimit': '-285', 'upperLimit': '13'}]}]}, {'title': 'Visit 6, Month 15', 'denoms': [{'units': 'Participants', 'counts': [{'value': '137', 'groupId': 'OG000'}, {'value': '67', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-0.9', 'groupId': 'OG000', 'lowerLimit': '-22', 'upperLimit': '166'}, {'value': '-0.7', 'groupId': 'OG001', 'lowerLimit': '-23', 'upperLimit': '245'}]}]}, {'title': 'Visit 7, Month 18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '131', 'groupId': 'OG000'}, {'value': '57', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-1.2', 'groupId': 'OG000', 'lowerLimit': '-99', 'upperLimit': '111'}, {'value': '-0.4', 'groupId': 'OG001', 'lowerLimit': '-28', 'upperLimit': '65'}]}]}, {'title': 'Visit 8, Month 21', 'denoms': [{'units': 'Participants', 'counts': [{'value': '125', 'groupId': 'OG000'}, {'value': '61', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-1.5', 'groupId': 'OG000', 'lowerLimit': '-200', 'upperLimit': '145'}, {'value': '-1.1', 'groupId': 'OG001', 'lowerLimit': '-287', 'upperLimit': '12'}]}]}, {'title': 'Visit 9, Month 24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '111', 'groupId': 'OG000'}, {'value': '54', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-0.8', 'groupId': 'OG000', 'lowerLimit': '-196', 'upperLimit': '141'}, {'value': '-1.5', 'groupId': 'OG001', 'lowerLimit': '-113', 'upperLimit': '15'}]}]}, {'title': 'Visit 10, Month 30', 'denoms': [{'units': 'Participants', 'counts': [{'value': '103', 'groupId': 'OG000'}, {'value': '56', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-1.4', 'groupId': 'OG000', 'lowerLimit': '-199', 'upperLimit': '14'}, {'value': '-0.4', 'groupId': 'OG001', 'lowerLimit': '-282', 'upperLimit': '126'}]}]}, {'title': 'Visit 11, Month 36', 'denoms': [{'units': 'Participants', 'counts': [{'value': '88', 'groupId': 'OG000'}, {'value': '50', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-1.8', 'groupId': 'OG000', 'lowerLimit': '-200', 'upperLimit': '137'}, {'value': '-3.2', 'groupId': 'OG001', 'lowerLimit': '-282', 'upperLimit': '11'}]}]}, {'title': 'Visit 12, Month 40', 'denoms': [{'units': 'Participants', 'counts': [{'value': '81', 'groupId': 'OG000'}, {'value': '47', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-1.6', 'groupId': 'OG000', 'lowerLimit': '-196', 'upperLimit': '129'}, {'value': '-1.7', 'groupId': 'OG001', 'lowerLimit': '-112', 'upperLimit': '10'}]}]}, {'title': 'Visit 13, Month 48', 'denoms': [{'units': 'Participants', 'counts': [{'value': '62', 'groupId': 'OG000'}, {'value': '45', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-0.9', 'groupId': 'OG000', 'lowerLimit': '-192', 'upperLimit': '58'}, {'value': '-1.9', 'groupId': 'OG001', 'lowerLimit': '-286', 'upperLimit': '125'}]}]}, {'title': 'Visit 14, Month 54', 'denoms': [{'units': 'Participants', 'counts': [{'value': '56', 'groupId': 'OG000'}, {'value': '37', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-1.3', 'groupId': 'OG000', 'lowerLimit': '-98', 'upperLimit': '145'}, {'value': '-1.9', 'groupId': 'OG001', 'lowerLimit': '-286', 'upperLimit': '83'}]}]}, {'title': 'Visit 15 (EOT), Month 60', 'denoms': [{'units': 'Participants', 'counts': [{'value': '43', 'groupId': 'OG000'}, {'value': '30', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-1.9', 'groupId': 'OG000', 'lowerLimit': '-101', 'upperLimit': '14'}, {'value': '-0.8', 'groupId': 'OG001', 'lowerLimit': '-286', 'upperLimit': '13'}]}]}], 'paramType': 'MEDIAN', 'timeFrame': 'From baseline upto 5 years (every 3 months from the first 2 years of the study; every 6 months for the last 3 years of the study)', 'description': 'Change from baseline in hepatic enzyme level (bilirubin) is presented.', 'unitOfMeasure': 'umol/L', 'dispersionType': 'Full Range', 'reportingStatus': 'POSTED', 'populationDescription': 'The safety analysis set comprised of all subjects treated with at least one dose of medicinal product. The data was restricted to main treatment period (from signing of informed consent and administration of first dose until loss to follow-up, change/discontinuation in ADT, or end-of-study visit, whatever came first).'}, {'type': 'PRIMARY', 'title': 'Change in Serum Glucose', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1000', 'groupId': 'OG000'}, {'value': '493', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'FIRMAGON', 'description': 'FIRMAGON (Degarelix, a GnRH antagonist) was prescribed in accordance with the approved label'}, {'id': 'OG001', 'title': 'GnRH Agonist', 'description': 'Any GnRH agonist prescribed in accordance with the approved labels'}], 'classes': [{'title': 'Visit 2, Month 3', 'denoms': [{'units': 'Participants', 'counts': [{'value': '225', 'groupId': 'OG000'}, {'value': '89', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-5', 'upperLimit': '9'}, {'value': '0.0', 'groupId': 'OG001', 'lowerLimit': '-5', 'upperLimit': '6'}]}]}, {'title': 'Visit 3, Month 6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '202', 'groupId': 'OG000'}, {'value': '89', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-6', 'upperLimit': '4'}, {'value': '0.0', 'groupId': 'OG001', 'lowerLimit': '-11', 'upperLimit': '7'}]}]}, {'title': 'Visit 4, Month 9', 'denoms': [{'units': 'Participants', 'counts': [{'value': '183', 'groupId': 'OG000'}, {'value': '83', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.1', 'groupId': 'OG000', 'lowerLimit': '-7', 'upperLimit': '14'}, {'value': '0.1', 'groupId': 'OG001', 'lowerLimit': '-7', 'upperLimit': '5'}]}]}, {'title': 'Visit 5, Month 12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '166', 'groupId': 'OG000'}, {'value': '91', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-8', 'upperLimit': '6'}, {'value': '0.0', 'groupId': 'OG001', 'lowerLimit': '-14', 'upperLimit': '9'}]}]}, {'title': 'Visit 6, Month 15', 'denoms': [{'units': 'Participants', 'counts': [{'value': '158', 'groupId': 'OG000'}, {'value': '79', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-6', 'upperLimit': '5'}, {'value': '0.2', 'groupId': 'OG001', 'lowerLimit': '-8', 'upperLimit': '6'}]}]}, {'title': 'Visit 7, Month 18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '149', 'groupId': 'OG000'}, {'value': '83', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-8', 'upperLimit': '3'}, {'value': '0.2', 'groupId': 'OG001', 'lowerLimit': '-13', 'upperLimit': '6'}]}]}, {'title': 'Visit 8, Month 21', 'denoms': [{'units': 'Participants', 'counts': [{'value': '146', 'groupId': 'OG000'}, {'value': '79', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-9', 'upperLimit': '5'}, {'value': '0.1', 'groupId': 'OG001', 'lowerLimit': '-12', 'upperLimit': '6'}]}]}, {'title': 'Visit 9, Month 24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '129', 'groupId': 'OG000'}, {'value': '76', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-6', 'upperLimit': '4'}, {'value': '-0.2', 'groupId': 'OG001', 'lowerLimit': '-4', 'upperLimit': '6'}]}]}, {'title': 'Visit 10, Month 30', 'denoms': [{'units': 'Participants', 'counts': [{'value': '123', 'groupId': 'OG000'}, {'value': '74', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-6', 'upperLimit': '4'}, {'value': '0.0', 'groupId': 'OG001', 'lowerLimit': '-8', 'upperLimit': '7'}]}]}, {'title': 'Visit 11, Month 36', 'denoms': [{'units': 'Participants', 'counts': [{'value': '114', 'groupId': 'OG000'}, {'value': '71', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-6', 'upperLimit': '4'}, {'value': '0.2', 'groupId': 'OG001', 'lowerLimit': '-5', 'upperLimit': '9'}]}]}, {'title': 'Visit 12, Month 42', 'denoms': [{'units': 'Participants', 'counts': [{'value': '103', 'groupId': 'OG000'}, {'value': '52', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.1', 'groupId': 'OG000', 'lowerLimit': '-6', 'upperLimit': '4'}, {'value': '-0.1', 'groupId': 'OG001', 'lowerLimit': '-4', 'upperLimit': '2'}]}]}, {'title': 'Visit 13, Month 48', 'denoms': [{'units': 'Participants', 'counts': [{'value': '78', 'groupId': 'OG000'}, {'value': '51', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.2', 'groupId': 'OG000', 'lowerLimit': '-3', 'upperLimit': '8'}, {'value': '0.0', 'groupId': 'OG001', 'lowerLimit': '-6', 'upperLimit': '6'}]}]}, {'title': 'Visit 14, Month 54', 'denoms': [{'units': 'Participants', 'counts': [{'value': '66', 'groupId': 'OG000'}, {'value': '48', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000', 'lowerLimit': '-5', 'upperLimit': '3'}, {'value': '0.1', 'groupId': 'OG001', 'lowerLimit': '-10', 'upperLimit': '9'}]}]}, {'title': 'Visit 15 (EOT), Month 60', 'denoms': [{'units': 'Participants', 'counts': [{'value': '52', 'groupId': 'OG000'}, {'value': '37', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '0.1', 'groupId': 'OG000', 'lowerLimit': '-1', 'upperLimit': '9'}, {'value': '0.2', 'groupId': 'OG001', 'lowerLimit': '-10', 'upperLimit': '3'}]}]}], 'paramType': 'MEDIAN', 'timeFrame': 'From baseline upto 5 years (every 3 months from the first 2 years of the study; every 6 months for the last 3 years of the study)', 'description': 'Change from baseline in serum glucose are presented.', 'unitOfMeasure': 'mmol/L', 'dispersionType': 'Full Range', 'reportingStatus': 'POSTED', 'populationDescription': 'The safety analysis set comprised of all subjects treated with at least one dose of medicinal product. The data was restricted to main treatment period (from signing of informed consent and administration of first dose until loss to follow-up, change/discontinuation in ADT, or end-of-study visit, whatever came first).'}, {'type': 'SECONDARY', 'title': 'Number and Classification of New Adverse Drug Reactions (ADRs)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1000', 'groupId': 'OG000'}, {'value': '493', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'FIRMAGON', 'description': 'FIRMAGON (Degarelix, a GnRH antagonist) was prescribed in accordance with the approved label'}, {'id': 'OG001', 'title': 'GnRH Agonist', 'description': 'Any GnRH agonist prescribed in accordance with the approved labels'}], 'classes': [{'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'From baseline upto 5 years (every 3 months from the first 2 years of the study; every 6 months for the last 3 years of the study)', 'description': 'An ADR was defined as an AE assessed by investigator as possibly/probably related to the investigational product. Any new potentially unrecognized ADRs were presented.', 'unitOfMeasure': 'New ADR', 'reportingStatus': 'POSTED', 'populationDescription': 'The safety analysis set comprised of all subjects treated with at least one dose of medicinal product. The data was restricted to main treatment period (from signing of informed consent and administration of first dose until loss to follow-up, change/discontinuation in ADT, or end-of-study visit, whatever came first).'}, {'type': 'SECONDARY', 'title': 'Long Term Evaluation of Clinical Evolution of Prostate Cancer', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1000', 'groupId': 'OG000'}, {'value': '493', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'FIRMAGON', 'description': 'FIRMAGON (Degarelix, a GnRH antagonist) was prescribed in accordance with the approved label'}, {'id': 'OG001', 'title': 'GnRH Agonist', 'description': 'Any GnRH prescribed in accordance with the approved labels'}], 'classes': [{'title': 'Visit 2, Month 3', 'denoms': [{'units': 'Participants', 'counts': [{'value': '709', 'groupId': 'OG000'}, {'value': '348', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-20.1', 'groupId': 'OG000', 'lowerLimit': '-788', 'upperLimit': '297'}, {'value': '-10.7', 'groupId': 'OG001', 'lowerLimit': '-438', 'upperLimit': '160'}]}]}, {'title': 'Visit 3, Month 6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '657', 'groupId': 'OG000'}, {'value': '358', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-19.1', 'groupId': 'OG000', 'lowerLimit': '-789', 'upperLimit': '161'}, {'value': '-11.4', 'groupId': 'OG001', 'lowerLimit': '-466', 'upperLimit': '399'}]}]}, {'title': 'Visit 4, Month 9', 'denoms': [{'units': 'Participants', 'counts': [{'value': '625', 'groupId': 'OG000'}, {'value': '326', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-17.0', 'groupId': 'OG000', 'lowerLimit': '-788', 'upperLimit': '583'}, {'value': '-11.5', 'groupId': 'OG001', 'lowerLimit': '-477', 'upperLimit': '260'}]}]}, {'title': 'Visit 5, Month 12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '575', 'groupId': 'OG000'}, {'value': '340', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-17.5', 'groupId': 'OG000', 'lowerLimit': '-787', 'upperLimit': '578'}, {'value': '-12.9', 'groupId': 'OG001', 'lowerLimit': '-465', 'upperLimit': '311'}]}]}, {'title': 'Visit 6, Month 15', 'denoms': [{'units': 'Participants', 'counts': [{'value': '526', 'groupId': 'OG000'}, {'value': '318', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-15.8', 'groupId': 'OG000', 'lowerLimit': '-783', 'upperLimit': '493'}, {'value': '-11.0', 'groupId': 'OG001', 'lowerLimit': '-472', 'upperLimit': '648'}]}]}, {'title': 'Visit 7, Month 18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '499', 'groupId': 'OG000'}, {'value': '304', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-16.0', 'groupId': 'OG000', 'lowerLimit': '-770', 'upperLimit': '665'}, {'value': '-11.3', 'groupId': 'OG001', 'lowerLimit': '-477', 'upperLimit': '790'}]}]}, {'title': 'Visit 8, Month 21', 'denoms': [{'units': 'Participants', 'counts': [{'value': '450', 'groupId': 'OG000'}, {'value': '279', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-14.4', 'groupId': 'OG000', 'lowerLimit': '-770', 'upperLimit': '201'}, {'value': '-11.0', 'groupId': 'OG001', 'lowerLimit': '-485', 'upperLimit': '567'}]}]}, {'title': 'Visit 9, Month 24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '421', 'groupId': 'OG000'}, {'value': '282', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-14.0', 'groupId': 'OG000', 'lowerLimit': '-770', 'upperLimit': '325'}, {'value': '-11.9', 'groupId': 'OG001', 'lowerLimit': '-442', 'upperLimit': '297'}]}]}, {'title': 'Visit 10, Month 30', 'denoms': [{'units': 'Participants', 'counts': [{'value': '395', 'groupId': 'OG000'}, {'value': '270', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-14.6', 'groupId': 'OG000', 'lowerLimit': '-770', 'upperLimit': '692'}, {'value': '-11.7', 'groupId': 'OG001', 'lowerLimit': '-488', 'upperLimit': '394'}]}]}, {'title': 'Visit 11, Month 36', 'denoms': [{'units': 'Participants', 'counts': [{'value': '352', 'groupId': 'OG000'}, {'value': '257', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-15.4', 'groupId': 'OG000', 'lowerLimit': '-770', 'upperLimit': '410'}, {'value': '-11.4', 'groupId': 'OG001', 'lowerLimit': '-485', 'upperLimit': '590'}]}]}, {'title': 'Visit 12, Month 42', 'denoms': [{'units': 'Participants', 'counts': [{'value': '309', 'groupId': 'OG000'}, {'value': '229', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-16.7', 'groupId': 'OG000', 'lowerLimit': '-770', 'upperLimit': '548'}, {'value': '-10.5', 'groupId': 'OG001', 'lowerLimit': '-486', 'upperLimit': '498'}]}]}, {'title': 'Visit 13, Month 48', 'denoms': [{'units': 'Participants', 'counts': [{'value': '270', 'groupId': 'OG000'}, {'value': '210', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-15.1', 'groupId': 'OG000', 'lowerLimit': '-770', 'upperLimit': '487'}, {'value': '-9.5', 'groupId': 'OG001', 'lowerLimit': '-484', 'upperLimit': '248'}]}]}, {'title': 'Visit 14, Month 54', 'denoms': [{'units': 'Participants', 'counts': [{'value': '246', 'groupId': 'OG000'}, {'value': '192', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-13.0', 'groupId': 'OG000', 'lowerLimit': '-770', 'upperLimit': '204'}, {'value': '-8.9', 'groupId': 'OG001', 'lowerLimit': '-482', 'upperLimit': '98'}]}]}, {'title': 'Visit 15 (EOT), Month 69', 'denoms': [{'units': 'Participants', 'counts': [{'value': '177', 'groupId': 'OG000'}, {'value': '145', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-14.7', 'groupId': 'OG000', 'lowerLimit': '-770', 'upperLimit': '405'}, {'value': '-9.0', 'groupId': 'OG001', 'lowerLimit': '-407', 'upperLimit': '39'}]}]}], 'paramType': 'MEDIAN', 'timeFrame': 'From baseline upto 5 years (every 3 months from the first 2 years of the study; every 6 months for the last 3 years of the study)', 'description': 'Change in prostate specific antigen (PSA) is presented.', 'unitOfMeasure': 'ng/mL', 'dispersionType': 'Full Range', 'reportingStatus': 'POSTED', 'populationDescription': 'The safety analysis set comprised of all subjects treated with at least one dose of medicinal product. The data was restricted to main treatment period (from signing of informed consent and administration of first dose until loss to follow-up, change/discontinuation in ADT, or end-of-study visit, whatever came first).'}, {'type': 'SECONDARY', 'title': 'Changes in Testosterone Levels', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1000', 'groupId': 'OG000'}, {'value': '493', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'FIRMAGON', 'description': 'FIRMAGON (Degarelix, a GnRH antagonist) was prescribed in accordance with the approved label'}, {'id': 'OG001', 'title': 'GnRH Agonist', 'description': 'Any GnRH agonist prescribed in accordance with the approved labels'}], 'classes': [{'title': 'Visit 2, Month 3', 'denoms': [{'units': 'Participants', 'counts': [{'value': '195', 'groupId': 'OG000'}, {'value': '110', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-3.6', 'groupId': 'OG000', 'lowerLimit': '-38', 'upperLimit': '33'}, {'value': '-3.0', 'groupId': 'OG001', 'lowerLimit': '-10', 'upperLimit': '30'}]}]}, {'title': 'Visit 3, Month 6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '158', 'groupId': 'OG000'}, {'value': '99', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-3.8', 'groupId': 'OG000', 'lowerLimit': '-38', 'upperLimit': '17'}, {'value': '-3.3', 'groupId': 'OG001', 'lowerLimit': '-19', 'upperLimit': '0'}]}]}, {'title': 'Visit 4, Month 9', 'denoms': [{'units': 'Participants', 'counts': [{'value': '155', 'groupId': 'OG000'}, {'value': '94', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-3.6', 'groupId': 'OG000', 'lowerLimit': '-38', 'upperLimit': '53'}, {'value': '-3.190', 'groupId': 'OG001', 'lowerLimit': '-10.16', 'upperLimit': '-0.03'}]}]}, {'title': 'Visit 5, Month 12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '136', 'groupId': 'OG000'}, {'value': '85', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-3.6', 'groupId': 'OG000', 'lowerLimit': '-38', 'upperLimit': '9'}, {'value': '-3.236', 'groupId': 'OG001', 'lowerLimit': '-9.79', 'upperLimit': '8.82'}]}]}, {'title': 'Visit 6, Month 15', 'denoms': [{'units': 'Participants', 'counts': [{'value': '110', 'groupId': 'OG000'}, {'value': '76', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-3.5', 'groupId': 'OG000', 'lowerLimit': '-38', 'upperLimit': '10'}, {'value': '-3.146', 'groupId': 'OG001', 'lowerLimit': '-10.16', 'upperLimit': '0.10'}]}]}, {'title': 'Visit 7, Month 18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '118', 'groupId': 'OG000'}, {'value': '74', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-3.6', 'groupId': 'OG000', 'lowerLimit': '-22', 'upperLimit': '35'}, {'value': '-3.127', 'groupId': 'OG001', 'lowerLimit': '-9.79', 'upperLimit': '5.34'}]}]}, {'title': 'Visit 8, Month 21', 'denoms': [{'units': 'Participants', 'counts': [{'value': '91', 'groupId': 'OG000'}, {'value': '73', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-3.3', 'groupId': 'OG000', 'lowerLimit': '-38', 'upperLimit': '22'}, {'value': '-3.175', 'groupId': 'OG001', 'lowerLimit': '-9.80', 'upperLimit': '-0.03'}]}]}, {'title': 'Visit 9, Month 24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '91', 'groupId': 'OG000'}, {'value': '63', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-3.5', 'groupId': 'OG000', 'lowerLimit': '-37', 'upperLimit': '19'}, {'value': '-3.041', 'groupId': 'OG001', 'lowerLimit': '-9.80', 'upperLimit': '1.14'}]}]}, {'title': 'Visit 10, Month 30', 'denoms': [{'units': 'Participants', 'counts': [{'value': '82', 'groupId': 'OG000'}, {'value': '68', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-3.5', 'groupId': 'OG000', 'lowerLimit': '-22', 'upperLimit': '2'}, {'value': '-2.847', 'groupId': 'OG001', 'lowerLimit': '-9.78', 'upperLimit': '3.57'}]}]}, {'title': 'Visit 11, Month 36', 'denoms': [{'units': 'Participants', 'counts': [{'value': '75', 'groupId': 'OG000'}, {'value': '63', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-3.7', 'groupId': 'OG000', 'lowerLimit': '-22', 'upperLimit': '2'}, {'value': '-2.977', 'groupId': 'OG001', 'lowerLimit': '-9.78', 'upperLimit': '3.85'}]}]}, {'title': 'Visit 12, Month 42', 'denoms': [{'units': 'Participants', 'counts': [{'value': '69', 'groupId': 'OG000'}, {'value': '52', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-3.7', 'groupId': 'OG000', 'lowerLimit': '-22', 'upperLimit': '2'}, {'value': '-2.835', 'groupId': 'OG001', 'lowerLimit': '-9.65', 'upperLimit': '0.13'}]}]}, {'title': 'Visit 13, Month 48', 'denoms': [{'units': 'Participants', 'counts': [{'value': '61', 'groupId': 'OG000'}, {'value': '56', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-3.930', 'groupId': 'OG000', 'lowerLimit': '-22.00', 'upperLimit': '10.78'}, {'value': '-2.6', 'groupId': 'OG001', 'lowerLimit': '-10', 'upperLimit': '4'}]}]}, {'title': 'Visit 14, Month 54', 'denoms': [{'units': 'Participants', 'counts': [{'value': '51', 'groupId': 'OG000'}, {'value': '49', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-3.380', 'groupId': 'OG000', 'lowerLimit': '-22.23', 'upperLimit': '7.35'}, {'value': '-2.463', 'groupId': 'OG001', 'lowerLimit': '-9.61', 'upperLimit': '3.60'}]}]}, {'title': 'Visit 15 (EOT), Month 60', 'denoms': [{'units': 'Participants', 'counts': [{'value': '44', 'groupId': 'OG000'}, {'value': '46', 'groupId': 'OG001'}]}], 'categories': [{'measurements': [{'value': '-3.870', 'groupId': 'OG000', 'lowerLimit': '-22.23', 'upperLimit': '1.61'}, {'value': '-2.2', 'groupId': 'OG001', 'lowerLimit': '-8', 'upperLimit': '3'}]}]}], 'paramType': 'MEDIAN', 'timeFrame': 'From baseline upto 5 years (every 3 months from the first 2 years of the study; every 6 months for the last 3 years of the study)', 'description': 'Change from baseline in testosterone levels are presented.', 'unitOfMeasure': 'ng/mL', 'dispersionType': 'Full Range', 'reportingStatus': 'POSTED', 'populationDescription': 'The safety analysis set comprised of all subjects treated with at least one dose of medicinal product. The data was restricted to main treatment period (from signing of informed consent and administration of first dose until loss to follow-up, change/discontinuation in ADT, or end-of-study visit, whatever came first).'}, {'type': 'SECONDARY', 'title': 'All-cause of Mortality', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1000', 'groupId': 'OG000'}, {'value': '493', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'FIRMAGON', 'description': 'FIRMAGON (Degarelix, a GnRH antagonist) was prescribed in accordance with the approved label'}, {'id': 'OG001', 'title': 'GnRH Agonist', 'description': 'Any GnRH agonist prescribed in accordance with the approved labels'}], 'classes': [{'categories': [{'measurements': [{'value': '6.5', 'groupId': 'OG000'}, {'value': '5.1', 'groupId': 'OG001'}]}]}], 'analyses': [{'pValue': '0.0821', 'groupIds': ['OG000', 'OG001'], 'paramType': 'Odds Ratio (OR)', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '0.747', 'ciLowerLimit': '0.537', 'ciUpperLimit': '1.038', 'pValueComment': 'A logistic regression was used to model the influence of age, stage of disease and relevant medical history along with the treatment group on the time to event for all-cause mortality.', 'groupDescription': 'The analyses of all-cause mortality was based on logistic regressions.', 'statisticalMethod': 'Regression, Logistic', 'nonInferiorityType': 'OTHER', 'statisticalComment': 'Logistic regression was used to model the influence of age, stage of disease and relevant medical history along with the treatment group.'}], 'paramType': 'NUMBER', 'timeFrame': 'From baseline upto 5 years (every 3 months from the first 2 years of the study; every 6 months for the last 3 years of the study)', 'description': 'A summary of IRs of all-cause mortality is presented.', 'unitOfMeasure': 'Events per 100 PYE', 'reportingStatus': 'POSTED', 'populationDescription': 'The safety analysis set comprised of all subjects treated with at least one dose of medicinal product. The data was restricted to main treatment period (from signing of informed consent and administration of first dose until loss to follow-up, change/discontinuation in ADT, or end-of-study visit, whatever came first).'}]}, 'participantFlowModule': {'groups': [{'id': 'FG000', 'title': 'FIRMAGON', 'description': 'FIRMAGON (Degarelix, a GnRH antagonist) was prescribed in accordance with the approved label'}, {'id': 'FG001', 'title': 'GnRH Agonist', 'description': 'Any GnRH agonist prescribed in accordance with the approved labels'}], 'periods': [{'title': 'Overall Study', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '1000'}, {'groupId': 'FG001', 'numSubjects': '493'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '313'}, {'groupId': 'FG001', 'numSubjects': '226'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '687'}, {'groupId': 'FG001', 'numSubjects': '267'}]}], 'dropWithdraws': [{'type': 'Adverse Event', 'reasons': [{'groupId': 'FG000', 'numSubjects': '277'}, {'groupId': 'FG001', 'numSubjects': '92'}]}, {'type': 'Withdrawal by Subject', 'reasons': [{'groupId': 'FG000', 'numSubjects': '61'}, {'groupId': 'FG001', 'numSubjects': '36'}]}, {'type': 'Lost to Follow-up', 'reasons': [{'groupId': 'FG000', 'numSubjects': '115'}, {'groupId': 'FG001', 'numSubjects': '47'}]}, {'type': 'Covers a diverse set of reasons', 'reasons': [{'groupId': 'FG000', 'numSubjects': '234'}, {'groupId': 'FG001', 'numSubjects': '92'}]}]}], 'recruitmentDetails': 'A total of 136 sites in 15 European countries (Belgium, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Netherlands, Norway, Portugal, Slovakia, Switzerland, United Kingdom) recruited subjects to this observational study between January 2011 to April 2013, and the last subject completed the last visit in March 2018.', 'preAssignmentDetails': 'A total of 1,515 subjects were screened, of which 1,493 subjects were found to be eligible and exposed to treatment; 1,000 subjects in the FIRMAGON group and 493 subjects in the gonadotrophin releasing hormone (GnRH) agonist group.'}, 'baselineCharacteristicsModule': {'denoms': [{'units': 'Participants', 'counts': [{'value': '1000', 'groupId': 'BG000'}, {'value': '493', 'groupId': 'BG001'}, {'value': '1493', 'groupId': 'BG002'}]}], 'groups': [{'id': 'BG000', 'title': 'FIRMAGON', 'description': 'FIRMAGON (Degarelix, a GnRH antagonist) was prescribed in accordance with the approved label'}, {'id': 'BG001', 'title': 'GnRH Agonist', 'description': 'Any GnRH agonist prescribed in accordance with the approved labels'}, {'id': 'BG002', 'title': 'Total', 'description': 'Total of all reporting groups'}], 'measures': [{'title': 'Age, Continuous', 'classes': [{'title': 'Age', 'denoms': [{'units': 'Participants', 'counts': [{'value': '999', 'groupId': 'BG000'}, {'value': '493', 'groupId': 'BG001'}, {'value': '1492', 'groupId': 'BG002'}]}], 'categories': [{'measurements': [{'value': '71.9', 'spread': '8.33', 'groupId': 'BG000'}, {'value': '73.2', 'spread': '8.27', 'groupId': 'BG001'}, {'value': '72.4', 'spread': '8.33', 'groupId': 'BG002'}]}]}], 'paramType': 'MEAN', 'unitOfMeasure': 'years', 'dispersionType': 'STANDARD_DEVIATION', 'populationDescription': 'Number analyzed differs from the overall population as age was not recorded for some of the subjects.'}, {'title': 'Sex: Female, Male', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '1000', 'groupId': 'BG000'}, {'value': '493', 'groupId': 'BG001'}, {'value': '1493', 'groupId': 'BG002'}]}], 'categories': [{'title': 'Female', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}]}, {'title': 'Male', 'measurements': [{'value': '1000', 'groupId': 'BG000'}, {'value': '493', 'groupId': 'BG001'}, {'value': '1493', 'groupId': 'BG002'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Ethnicity (NIH/OMB)', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '780', 'groupId': 'BG000'}, {'value': '385', 'groupId': 'BG001'}, {'value': '1165', 'groupId': 'BG002'}]}], 'categories': [{'title': 'Hispanic or Latino', 'measurements': [{'value': '12', 'groupId': 'BG000'}, {'value': '5', 'groupId': 'BG001'}, {'value': '17', 'groupId': 'BG002'}]}, {'title': 'Not Hispanic or Latino', 'measurements': [{'value': '697', 'groupId': 'BG000'}, {'value': '353', 'groupId': 'BG001'}, {'value': '1050', 'groupId': 'BG002'}]}, {'title': 'Unknown or Not Reported', 'measurements': [{'value': '71', 'groupId': 'BG000'}, {'value': '27', 'groupId': 'BG001'}, {'value': '98', 'groupId': 'BG002'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants', 'populationDescription': 'Ethnicity was not recorded for some subjects.'}, {'title': 'Race (NIH/OMB)', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '780', 'groupId': 'BG000'}, {'value': '385', 'groupId': 'BG001'}, {'value': '1165', 'groupId': 'BG002'}]}], 'categories': [{'title': 'American Indian or Alaska Native', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '1', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}]}, {'title': 'Asian', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '2', 'groupId': 'BG001'}, {'value': '2', 'groupId': 'BG002'}]}, {'title': 'Native Hawaiian or Other Pacific Islander', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}]}, {'title': 'Black or African American', 'measurements': [{'value': '9', 'groupId': 'BG000'}, {'value': '14', 'groupId': 'BG001'}, {'value': '23', 'groupId': 'BG002'}]}, {'title': 'White', 'measurements': [{'value': '745', 'groupId': 'BG000'}, {'value': '360', 'groupId': 'BG001'}, {'value': '1105', 'groupId': 'BG002'}]}, {'title': 'More than one race', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}]}, {'title': 'Unknown or Not Reported', 'measurements': [{'value': '26', 'groupId': 'BG000'}, {'value': '8', 'groupId': 'BG001'}, {'value': '34', 'groupId': 'BG002'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants', 'populationDescription': 'Number analyzed differs from the overall population as race was not recorded for some of the subjects.'}, {'title': 'BMI (kg/m^2)', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '786', 'groupId': 'BG000'}, {'value': '406', 'groupId': 'BG001'}, {'value': '1192', 'groupId': 'BG002'}]}], 'categories': [{'measurements': [{'value': '27', 'spread': '3.91', 'groupId': 'BG000'}, {'value': '26.8', 'spread': '3.82', 'groupId': 'BG001'}, {'value': '26.9', 'spread': '3.88', 'groupId': 'BG002'}]}]}], 'paramType': 'MEAN', 'unitOfMeasure': 'kg/m^2', 'dispersionType': 'STANDARD_DEVIATION', 'populationDescription': 'Number analyzed differs from the overall population as baseline body mass index (BMI) was not calculated for some of the subjects.'}], 'populationDescription': 'The safety analysis set comprised of all subjects treated with at least one dose of medicinal product. The data was restricted to main treatment period (from signing of informed consent and administration of first dose until loss to follow-up, change/discontinuation in androgen deprivation therapy \\[ADT\\], or end-of-study visit, whatever came first).'}}, 'documentSection': {'largeDocumentModule': {'largeDocs': [{'date': '2010-06-01', 'size': 1160431, 'label': 'Study Protocol', 'hasIcf': False, 'hasSap': False, 'filename': 'Prot_000.pdf', 'typeAbbrev': 'Prot', 'uploadDate': '2019-02-21T06:18', 'hasProtocol': True}, {'date': '2014-08-08', 'size': 505529, 'label': 'Statistical Analysis Plan', 'hasIcf': False, 'hasSap': True, 'filename': 'SAP_001.pdf', 'typeAbbrev': 'SAP', 'uploadDate': '2019-02-21T06:19', 'hasProtocol': False}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'COHORT'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 1493}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2011-01'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2019-06', 'completionDateStruct': {'date': '2018-03-27', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2019-06-14', 'studyFirstSubmitDate': '2010-11-03', 'resultsFirstSubmitDate': '2019-02-21', 'studyFirstSubmitQcDate': '2010-11-03', 'lastUpdatePostDateStruct': {'date': '2019-06-25', 'type': 'ACTUAL'}, 'resultsFirstSubmitQcDate': '2019-02-21', 'studyFirstPostDateStruct': {'date': '2010-11-04', 'type': 'ESTIMATED'}, 'resultsFirstPostDateStruct': {'date': '2019-05-20', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2018-03-27', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Incidence Rate of Adverse Events of Special Interest (AESI): Cardiovascular Events', 'timeFrame': 'From baseline upto 5 years (every 3 months from the first 2 years of the study; every 6 months for the last 3 years of the study)', 'description': 'The incidence rate (IR) expressed as number of events per 100 patient-years of exposure (PYE).'}, {'measure': 'Incidence Rate of AESI: Decreased Bone Density', 'timeFrame': 'From baseline upto 5 years (every 3 months from the first 2 years of the study; every 6 months for the last 3 years of the study)', 'description': 'IR of osteoporosis or osteopenia and bone fracture events are presented. The IR is expressed as number of events per 100 PYE.'}, {'measure': 'Incidence Rate of AESI: Glucose Intolerance or Type 2 Diabetes Mellitus (T2DM)', 'timeFrame': 'From baseline upto 5 years (every 3 months from the first 2 years of the study; every 6 months for the last 3 years of the study)', 'description': 'IR of new onset or exacerbation of glucose intolerance or T2DM were presented. The IR expressed as number of events per 100 PYE.\n\nGlucose intolerance events were defined as events of levels of fasting glucose of 6.1 to 6.9 mmol/L'}, {'measure': 'Change in Hepatic Enzymes', 'timeFrame': 'From baseline upto 5 years (every 3 months from the first 2 years of the study; every 6 months for the last 3 years of the study)', 'description': 'Change from baseline in hepatic enzyme levels (alanine aminotransferase \\[ALT\\], aspartate aminotransferase \\[AST\\], and alkaline phosphatase \\[ALP\\]) are presented.'}, {'measure': 'Change in Hepatic Enzymes', 'timeFrame': 'From baseline upto 5 years (every 3 months from the first 2 years of the study; every 6 months for the last 3 years of the study)', 'description': 'Change from baseline in hepatic enzyme level (bilirubin) is presented.'}, {'measure': 'Change in Serum Glucose', 'timeFrame': 'From baseline upto 5 years (every 3 months from the first 2 years of the study; every 6 months for the last 3 years of the study)', 'description': 'Change from baseline in serum glucose are presented.'}], 'secondaryOutcomes': [{'measure': 'Number and Classification of New Adverse Drug Reactions (ADRs)', 'timeFrame': 'From baseline upto 5 years (every 3 months from the first 2 years of the study; every 6 months for the last 3 years of the study)', 'description': 'An ADR was defined as an AE assessed by investigator as possibly/probably related to the investigational product. Any new potentially unrecognized ADRs were presented.'}, {'measure': 'Long Term Evaluation of Clinical Evolution of Prostate Cancer', 'timeFrame': 'From baseline upto 5 years (every 3 months from the first 2 years of the study; every 6 months for the last 3 years of the study)', 'description': 'Change in prostate specific antigen (PSA) is presented.'}, {'measure': 'Changes in Testosterone Levels', 'timeFrame': 'From baseline upto 5 years (every 3 months from the first 2 years of the study; every 6 months for the last 3 years of the study)', 'description': 'Change from baseline in testosterone levels are presented.'}, {'measure': 'All-cause of Mortality', 'timeFrame': 'From baseline upto 5 years (every 3 months from the first 2 years of the study; every 6 months for the last 3 years of the study)', 'description': 'A summary of IRs of all-cause mortality is presented.'}]}, 'oversightModule': {'oversightHasDmc': True}, 'conditionsModule': {'conditions': ['Prostate Cancer']}, 'descriptionModule': {'briefSummary': 'This study is a large observational study, set-up to observe how long-term treatment with FIRMAGON (hormone regulator) compare to other treatments in regards to cardiovascular events, changes in bone density, changes in blood sugar levels or liver enzyme levels in subjects with prostate cancer. Subjects will be treated according to their routine clinical care and not dictated by the study. As the study is observational in nature, the study will collect data relating to the events specified above. Subjects that agree to this study will be followed-up for 5 years. Subject data will be collected every 3 months for the first 2 years and every 6 months for the last 3 years.'}, 'eligibilityModule': {'sex': 'MALE', 'stdAges': ['CHILD', 'ADULT', 'OLDER_ADULT'], 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Subjects with prostate cancer from primary care', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Diagnosed with prostate cancer and indicated for androgen deprivation therapy (ADT)\n* Decision made to prescribe ADT prior to enrolment\n* Willing and able to provide written informed consent\n\nExclusion Criteria:\n\n* Participation in an interventional clinical study in which any treatment or follow-up is mandated\n* Treatment with a GnRH receptor antagonist other than FIRMAGON\n* Had previous or is currently under hormonal management of prostate cancer, except for subjects who have undergone therapy with curative intention where neoadjuvant/adjuvant therapy allowed for maximum 6 months. Treatment should be terminated at least 6 months prior to baseline.'}, 'identificationModule': {'nctId': 'NCT01234350', 'briefTitle': 'A Safety Study in Patients With Advanced Prostate Cancer Treated With FIRMAGON', 'organization': {'class': 'INDUSTRY', 'fullName': 'Ferring Pharmaceuticals'}, 'officialTitle': 'A Prospective Observational Safety Study in Patients With Advanced Prostate Cancer Treated With FIRMAGON (Degarelix) or a GnRH Agonist', 'orgStudyIdInfo': {'id': 'FE200486 CS39'}}, 'armsInterventionsModule': {'armGroups': [{'label': 'FIRMAGON'}, {'label': 'GnRH Agonist'}]}, 'contactsLocationsModule': {'locations': [{'city': 'Aalst', 'country': 'Belgium', 'facility': 'Onze-Lieve-Vrouwziekenhuis', 'geoPoint': {'lat': 50.93604, 'lon': 4.0355}}, {'city': 'Antwerp', 'country': 'Belgium', 'facility': 'Ziekenhuisnetwerk Antwerpen - AZ Stuivenberg', 'geoPoint': {'lat': 51.22047, 'lon': 4.40026}}, {'city': 'Bruges', 'country': 'Belgium', 'facility': 'AZ Sint-Jan AV', 'geoPoint': {'lat': 51.20892, 'lon': 3.22424}}, {'city': 'Brussels', 'country': 'Belgium', 'facility': 'Hôpitaux IRIS Sud', 'geoPoint': {'lat': 50.85045, 'lon': 4.34878}}, {'city': 'Brussels', 'country': 'Belgium', 'facility': 'Université Catholique de Louvain', 'geoPoint': {'lat': 50.85045, 'lon': 4.34878}}, {'city': 'Bruxelle', 'country': 'Belgium', 'facility': 'Hôpital Erasme'}, {'city': 'Dendermonde', 'country': 'Belgium', 'facility': 'AZ Sint-Blasius', 'geoPoint': {'lat': 51.02869, 'lon': 4.10106}}, {'city': 'Ghent', 'country': 'Belgium', 'facility': 'AZ Jan Palfijn', 'geoPoint': {'lat': 51.05, 'lon': 3.71667}}, {'city': 'Ghent', 'country': 'Belgium', 'facility': 'AZ Maria Middelares', 'geoPoint': {'lat': 51.05, 'lon': 3.71667}}, {'city': 'Ghent', 'country': 'Belgium', 'facility': 'AZ Sint-Lucas', 'geoPoint': {'lat': 51.05, 'lon': 3.71667}}, {'city': 'Ghent', 'country': 'Belgium', 'facility': 'UZ Gent', 'geoPoint': {'lat': 51.05, 'lon': 3.71667}}, {'city': 'Ieper', 'country': 'Belgium', 'facility': 'Regionaal Ziekenhuis Jan Yperman VZW', 'geoPoint': {'lat': 50.85114, 'lon': 2.88569}}, {'city': 'Kortrijk', 'country': 'Belgium', 'facility': 'AZ Groeninge - Campus Sint-Maarten', 'geoPoint': {'lat': 50.82803, 'lon': 3.26487}}, {'city': 'Liège', 'country': 'Belgium', 'facility': 'CHU de Liège', 'geoPoint': {'lat': 50.63373, 'lon': 5.56749}}, {'city': 'Mons', 'country': 'Belgium', 'facility': 'Centre Hospitalier Universitaire Ambroise Paré', 'geoPoint': {'lat': 50.45413, 'lon': 3.95229}}, {'city': 'Ostend', 'country': 'Belgium', 'facility': 'AZ Damiaan', 'geoPoint': {'lat': 51.21551, 'lon': 2.927}}, {'city': 'Zottegem', 'country': 'Belgium', 'facility': 'AZ-Sint-Elizabeth VZW', 'geoPoint': {'lat': 50.86955, 'lon': 3.81052}}, {'city': 'Aalborg', 'country': 'Denmark', 'facility': 'Aalborg Sygehus', 'geoPoint': {'lat': 57.048, 'lon': 9.9187}}, {'city': 'Copenhagen', 'country': 'Denmark', 'facility': 'Rigshospitalet', 'geoPoint': {'lat': 55.67594, 'lon': 12.56553}}, {'city': 'Fredericia', 'country': 'Denmark', 'facility': 'Fredericia Hospital, Sygehus Lillebaelt', 'geoPoint': {'lat': 55.56568, 'lon': 9.75257}}, {'city': 'Herlev', 'country': 'Denmark', 'facility': 'Herlev Hospital', 'geoPoint': {'lat': 55.72366, 'lon': 12.43998}}, {'city': 'Holstebro', 'country': 'Denmark', 'facility': 'Holstebro Sygehus', 'geoPoint': {'lat': 56.36009, 'lon': 8.61607}}, {'city': 'Viborg', 'country': 'Denmark', 'facility': 'Regionhospitalet Viborg', 'geoPoint': {'lat': 56.45319, 'lon': 9.40201}}, {'city': 'Helsinki', 'country': 'Finland', 'facility': 'Docrates clinic', 'geoPoint': {'lat': 60.16952, 'lon': 24.93545}}, {'city': 'Joensuu', 'country': 'Finland', 'facility': 'Pohjois-Karjalan keskussairaala', 'geoPoint': {'lat': 62.60118, 'lon': 29.76316}}, {'city': 'Seinäjoki', 'country': 'Finland', 'facility': 'Seinäjoen keskussairaala', 'geoPoint': {'lat': 62.79446, 'lon': 22.82822}}, {'city': 'Tampere', 'country': 'Finland', 'facility': 'Tampereen yliopistollinen sairaala', 'geoPoint': {'lat': 61.49911, 'lon': 23.78712}}, {'city': 'Turku', 'country': 'Finland', 'facility': 'Turun yliopistollinen keskussairaala', 'geoPoint': {'lat': 60.45148, 'lon': 22.26869}}, {'city': 'Vantaa', 'country': 'Finland', 'facility': 'Peijaksen sairaala', 'geoPoint': {'lat': 60.29414, 'lon': 25.04099}}, {'city': 'Angers', 'country': 'France', 'facility': 'CHRU Angers', 'geoPoint': {'lat': 47.47156, 'lon': -0.55202}}, {'city': 'Athis-Mons', 'country': 'France', 'facility': "Centre Hospitalier d'Athis Mons site Caron", 'geoPoint': {'lat': 48.70522, 'lon': 2.39147}}, {'city': 'Aubervilliers', 'country': 'France', 'facility': 'Hopital Tenon', 'geoPoint': {'lat': 48.91667, 'lon': 2.38333}}, {'city': 'Avignon', 'country': 'France', 'facility': 'Clinique Rhone Durance', 'geoPoint': {'lat': 43.94834, 'lon': 4.80892}}, {'city': 'Besançon', 'country': 'France', 'facility': 'CHU Saint-Jacques', 'geoPoint': {'lat': 47.24878, 'lon': 6.01815}}, {'city': 'Clermont-Ferrand', 'country': 'France', 'facility': 'Centre Hospitalier Laennec', 'geoPoint': {'lat': 45.77969, 'lon': 3.08682}}, {'city': 'Clermont-Ferrand', 'country': 'France', 'facility': 'Chu Gabriel Montpied', 'geoPoint': {'lat': 45.77969, 'lon': 3.08682}}, {'city': 'Évry', 'country': 'France', 'facility': 'Ramsay Sante', 'geoPoint': {'lat': 48.6328, 'lon': 2.44049}}, {'city': 'Lyon', 'country': 'France', 'facility': 'Groupement hospitalier Edouard Herriot', 'geoPoint': {'lat': 45.74906, 'lon': 4.84789}}, {'city': 'Marseille', 'country': 'France', 'facility': 'Cabinet Médical 65 prado', 'geoPoint': {'lat': 43.29695, 'lon': 5.38107}}, {'city': 'Marseille', 'country': 'France', 'facility': 'CHU Nord', 'geoPoint': {'lat': 43.29695, 'lon': 5.38107}}, {'city': 'Marseille', 'country': 'France', 'facility': 'Hopital de la Conception', 'geoPoint': {'lat': 43.29695, 'lon': 5.38107}}, {'city': 'Melun', 'country': 'France', 'facility': 'Polyclinique Saint-Jean', 'geoPoint': {'lat': 48.5457, 'lon': 2.65356}}, {'city': 'Montauban', 'country': 'France', 'facility': 'Clinique du Pont de Chaume', 'geoPoint': {'lat': 44.01759, 'lon': 1.3542}}, {'city': 'Montpellier', 'country': 'France', 'facility': 'Clinique Beausoleil', 'geoPoint': {'lat': 43.61093, 'lon': 3.87635}}, {'city': 'Nancy', 'country': 'France', 'facility': "Centre d'Urologie de Nancy", 'geoPoint': {'lat': 48.68439, 'lon': 6.18496}}, {'city': 'Nanterre', 'country': 'France', 'facility': 'Hôpital Max Fourestier', 'geoPoint': {'lat': 48.89198, 'lon': 2.20675}}, {'city': 'Niort', 'country': 'France', 'facility': 'Centre Hospitalier Georges Renon', 'geoPoint': {'lat': 46.32313, 'lon': -0.45877}}, {'city': 'Nîmes', 'country': 'France', 'facility': 'Groupe hospitalo-universitaire Caremeau', 'geoPoint': {'lat': 43.83665, 'lon': 4.35788}}, {'city': 'Paris', 'country': 'France', 'facility': 'Hopital Tenon', 'geoPoint': {'lat': 48.85341, 'lon': 2.3488}}, {'city': 'Ploemeur', 'country': 'France', 'facility': 'Clinique du Ter', 'geoPoint': {'lat': 47.73512, 'lon': -3.42952}}, {'city': 'Pontoise', 'country': 'France', 'facility': "Clinic De L'Europe", 'geoPoint': {'lat': 49.05, 'lon': 2.1}}, {'city': 'Rennes', 'country': 'France', 'facility': 'Hopital Pontchaillou', 'geoPoint': {'lat': 48.11109, 'lon': -1.67431}}, {'city': 'Toulon', 'country': 'France', 'facility': 'Clinique Saint Michel', 'geoPoint': {'lat': 43.12442, 'lon': 5.92836}}, {'city': 'Toulouse', 'country': 'France', 'facility': 'Clinique St Jean Languedoc', 'geoPoint': {'lat': 43.60426, 'lon': 1.44367}}, {'city': 'Tours', 'country': 'France', 'facility': 'Hopital Bretonneau', 'geoPoint': {'lat': 47.39484, 'lon': 0.70398}}, {'city': 'Vandœuvre-lès-Nancy', 'country': 'France', 'facility': 'CHU Brabois', 'geoPoint': {'lat': 48.66115, 'lon': 6.17114}}, {'city': 'Aachen', 'country': 'Germany', 'facility': 'Gemeinschaftspraxis Dres Effert und Benedic', 'geoPoint': {'lat': 50.77664, 'lon': 6.08342}}, {'city': 'Bad Bergzaben', 'country': 'Germany', 'facility': 'Praxis Dr. Schlichter', 'geoPoint': {'lat': 49.10245, 'lon': 8.00092}}, {'city': 'Bautzen', 'country': 'Germany', 'facility': 'Praxis Dr. Markus Hentschel', 'geoPoint': {'lat': 51.18035, 'lon': 14.43494}}, {'city': 'Bonn', 'country': 'Germany', 'facility': 'Praxis Dr. Richter', 'geoPoint': {'lat': 50.73438, 'lon': 7.09549}}, {'city': 'Braunschweig', 'country': 'Germany', 'facility': 'Urologie im Schlosscarree', 'geoPoint': {'lat': 52.26594, 'lon': 10.52673}}, {'city': 'Bremerhaven', 'country': 'Germany', 'facility': 'Praxis Dr. Ahmad Haider', 'geoPoint': {'lat': 53.55357, 'lon': 8.57553}}, {'city': 'Chemnitz', 'country': 'Germany', 'facility': 'Praxis Dr. Krieger', 'geoPoint': {'lat': 50.8357, 'lon': 12.92922}}, {'city': 'Chemnitz', 'country': 'Germany', 'facility': 'Urologie Chemnitz', 'geoPoint': {'lat': 50.8357, 'lon': 12.92922}}, {'city': 'Cologne', 'country': 'Germany', 'facility': 'Praxis Dr. Thomas Harms', 'geoPoint': {'lat': 50.93333, 'lon': 6.95}}, {'city': 'Dachau', 'country': 'Germany', 'facility': 'Gemeinschaftspraxis fur Urologie', 'geoPoint': {'lat': 48.26, 'lon': 11.43402}}, {'city': 'Dinslaken', 'country': 'Germany', 'facility': 'Klinikpraxis fur Urologie', 'geoPoint': {'lat': 51.56227, 'lon': 6.7434}}, {'city': 'Hamburg', 'country': 'Germany', 'facility': 'Praxis Dr. Schönfelder', 'geoPoint': {'lat': 53.55073, 'lon': 9.99302}}, {'city': 'Kiel', 'country': 'Germany', 'facility': 'Gemeinschaftspraxis Urologie', 'geoPoint': {'lat': 54.32133, 'lon': 10.13489}}, {'city': 'Kiel', 'country': 'Germany', 'facility': 'Urologische Gemeinschaftspraxis', 'geoPoint': {'lat': 54.32133, 'lon': 10.13489}}, {'city': 'Kirchheim', 'country': 'Germany', 'facility': 'Gemeinshaftspraxis Rudolph & Wörner', 'geoPoint': {'lat': 50.83333, 'lon': 9.56667}}, {'city': 'Leipzig', 'country': 'Germany', 'facility': 'Vituro', 'geoPoint': {'lat': 51.33962, 'lon': 12.37129}}, {'city': 'Marburg', 'country': 'Germany', 'facility': 'Praxis Alexander von Keitz', 'geoPoint': {'lat': 50.80904, 'lon': 8.77069}}, {'city': 'Nienburg', 'country': 'Germany', 'facility': 'Praxis Dr. Peczat', 'geoPoint': {'lat': 52.6461, 'lon': 9.22086}}, {'city': 'Planegg', 'country': 'Germany', 'facility': 'Studienzentrum München-Planegg', 'geoPoint': {'lat': 48.10672, 'lon': 11.42483}}, {'city': 'Reutlingen', 'country': 'Germany', 'facility': 'Urologische Gemeinschaftspraxis', 'geoPoint': {'lat': 48.49144, 'lon': 9.20427}}, {'city': 'Tostedt', 'country': 'Germany', 'facility': 'Praxis Dr. Jan Franz', 'geoPoint': {'lat': 53.28333, 'lon': 9.71667}}, {'city': 'Wuppertal', 'country': 'Germany', 'facility': 'Praxis fur Urologie', 'geoPoint': {'lat': 51.25627, 'lon': 7.14816}}, {'city': 'Athens', 'country': 'Greece', 'facility': '"Agios Savas" Anticancer-Oncology Hospital of Athens', 'geoPoint': {'lat': 37.98376, 'lon': 23.72784}}, {'city': 'Athens', 'country': 'Greece', 'facility': '"G. Gennimtas" General Hospital of Athens', 'geoPoint': {'lat': 37.98376, 'lon': 23.72784}}, {'city': 'Athens', 'country': 'Greece', 'facility': '"Laiko" General Hospital of Athens', 'geoPoint': {'lat': 37.98376, 'lon': 23.72784}}, {'city': 'Athens', 'country': 'Greece', 'facility': 'Amalia Fleming General Hospital of Athens', 'geoPoint': {'lat': 37.98376, 'lon': 23.72784}}, {'city': 'Athens', 'country': 'Greece', 'facility': 'Errikos Dynan Hospital of Athens', 'geoPoint': {'lat': 37.98376, 'lon': 23.72784}}, {'city': 'Athens', 'country': 'Greece', 'facility': 'Eurokliniki Hospital of Athens', 'geoPoint': {'lat': 37.98376, 'lon': 23.72784}}, {'city': 'Athens', 'country': 'Greece', 'facility': 'Evaggelismos General Hospital', 'geoPoint': {'lat': 37.98376, 'lon': 23.72784}}, {'city': 'Athens', 'country': 'Greece', 'facility': 'General Hospital of Athens "Ag. Olga" - Konstantopouleion', 'geoPoint': {'lat': 37.98376, 'lon': 23.72784}}, {'city': 'Athens', 'country': 'Greece', 'facility': 'Ippokrateio Hospital of Athens', 'geoPoint': {'lat': 37.98376, 'lon': 23.72784}}, {'city': 'Athens', 'country': 'Greece', 'facility': 'Korgialenio-Benakio', 'geoPoint': {'lat': 37.98376, 'lon': 23.72784}}, {'city': 'Heraklion', 'country': 'Greece', 'facility': 'Pe. Pa.G.N:I Hospital', 'geoPoint': {'lat': 35.32787, 'lon': 25.14341}}, {'city': 'Kalamata', 'country': 'Greece', 'facility': 'General hospital of Kalamata', 'geoPoint': {'lat': 37.03913, 'lon': 22.11265}}, {'city': 'Kalamata', 'country': 'Greece', 'facility': 'IASO General Hospital', 'geoPoint': {'lat': 37.03913, 'lon': 22.11265}}, {'city': 'Larissa', 'country': 'Greece', 'facility': 'University Hospital of Larissa', 'geoPoint': {'lat': 39.62847, 'lon': 22.42112}}, {'zip': 'Greece', 'city': 'Pátrai', 'country': 'Greece', 'facility': 'Aghios Andreas General Hospital of Patras', 'geoPoint': {'lat': 38.2462, 'lon': 21.73508}}, {'city': 'Pátrai', 'country': 'Greece', 'facility': 'University General Hospital of Patras', 'geoPoint': {'lat': 38.2462, 'lon': 21.73508}}, {'city': 'Piraeus', 'country': 'Greece', 'facility': 'General Hospital of Piraeus "Tzanneio"', 'geoPoint': {'lat': 37.94203, 'lon': 23.64619}}, {'city': 'Thessaloniki', 'country': 'Greece', 'facility': '"G. Gennimtas" General Hospital of Thessaloniki', 'geoPoint': {'lat': 40.64072, 'lon': 22.93493}}, {'city': 'Thessaloniki', 'country': 'Greece', 'facility': '2nd IKA-ETAM "Panagia" General Hospital of Thessaloniki', 'geoPoint': {'lat': 40.64072, 'lon': 22.93493}}, {'city': 'Thessaloniki', 'country': 'Greece', 'facility': 'Papageorgiou General Hospital of Thessaloniki', 'geoPoint': {'lat': 40.64072, 'lon': 22.93493}}, {'city': 'Volos', 'country': 'Greece', 'facility': 'General Hospital of Volos "Achillopouleio"', 'geoPoint': {'lat': 39.36923, 'lon': 22.94769}}, {'city': 'Budapest', 'country': 'Hungary', 'facility': 'Azarka Zsuzsanna és Társa Bt', 'geoPoint': {'lat': 47.49835, 'lon': 19.04045}}, {'city': 'Debrecen', 'country': 'Hungary', 'facility': 'UROFOR Bt', 'geoPoint': {'lat': 47.53167, 'lon': 21.62444}}, {'city': 'Kiskunhalas', 'country': 'Hungary', 'facility': 'Kiskunhalasi Semmelweis Kórház Kht.', 'geoPoint': {'lat': 46.43402, 'lon': 19.48479}}, {'city': 'Miskolc', 'country': 'Hungary', 'facility': 'Miskolci Semmelweis Ignác Egészségügyi Központ és Egyetemi Oktató Kórház Nonprofit Kft', 'geoPoint': {'lat': 48.10327, 'lon': 20.77806}}, {'city': 'Pécs', 'country': 'Hungary', 'facility': 'Uro-Clin Kft', 'geoPoint': {'lat': 46.07617, 'lon': 18.22814}}, {'city': 'Székesfehérvár', 'country': 'Hungary', 'facility': 'FEjér Megyei Szent György Kórhaz', 'geoPoint': {'lat': 47.18995, 'lon': 18.41034}}, {'city': 'Dublin', 'country': 'Ireland', 'facility': 'Beacon Hospital', 'geoPoint': {'lat': 53.33306, 'lon': -6.24889}}, {'city': 'Dublin', 'country': 'Ireland', 'facility': 'Beaumont Hospital', 'geoPoint': {'lat': 53.33306, 'lon': -6.24889}}, {'city': 'Galway', 'country': 'Ireland', 'facility': 'University College Hospital', 'geoPoint': {'lat': 53.27245, 'lon': -9.05095}}, {'city': 'Avellino', 'country': 'Italy', 'facility': 'Medical Consulting Center S.r.l.', 'geoPoint': {'lat': 40.91494, 'lon': 14.79103}}, {'city': 'Campobasso', 'country': 'Italy', 'facility': 'Azienda Sanitaria Regionale del Molise (ASREM)', 'geoPoint': {'lat': 41.55947, 'lon': 14.66737}}, {'city': 'Catanzaro', 'country': 'Italy', 'facility': 'Azienda Ospedaliera Mater Domini di Catanzaro', 'geoPoint': {'lat': 38.88247, 'lon': 16.60086}}, {'city': 'Mantova', 'country': 'Italy', 'facility': 'Azienda Ospedaliera Carlo Poma', 'geoPoint': {'lat': 45.16031, 'lon': 10.79784}}, {'city': 'Milan', 'country': 'Italy', 'facility': 'Ospedale Luigi Sacco', 'geoPoint': {'lat': 42.78235, 'lon': 12.59836}}, {'city': 'Napoli', 'country': 'Italy', 'facility': 'Azienda Ospedaliera Monaldi', 'geoPoint': {'lat': 40.87618, 'lon': 14.5195}}, {'city': 'Nocera Inferiore', 'country': 'Italy', 'facility': 'Azienda Sanitaria Locale Salerno', 'geoPoint': {'lat': 40.7454, 'lon': 14.64542}}, {'city': 'Ravenna', 'country': 'Italy', 'facility': 'Ospedale Santa Maria delle Croci', 'geoPoint': {'lat': 44.41344, 'lon': 12.20121}}, {'city': 'Reggio Calabria', 'country': 'Italy', 'facility': 'Azienda Ospedaliera "Bianchi-Melacrino-Morelli"', 'geoPoint': {'lat': 38.11047, 'lon': 15.66129}}, {'city': 'Roma', 'country': 'Italy', 'facility': 'Istituto Nazionale Tumori "Regina Elena"', 'geoPoint': {'lat': 44.99364, 'lon': 11.10642}}, {'city': 'Salerno', 'country': 'Italy', 'facility': "Azienda Ospedaliera Universitaria OO.RR. S.Giovanni di Dio e Ruggi d'Aragona", 'geoPoint': {'lat': 40.67545, 'lon': 14.79328}}, {'city': 'Teramo', 'country': 'Italy', 'facility': 'ASL 4 di Teramo', 'geoPoint': {'lat': 42.66123, 'lon': 13.69901}}, {'city': 'Vasto', 'country': 'Italy', 'facility': 'Ospedale "San Pio da Pietrelcina"', 'geoPoint': {'lat': 42.1115, 'lon': 14.70649}}, {'city': 'Amsterdam', 'country': 'Netherlands', 'facility': 'AMC', 'geoPoint': {'lat': 52.37403, 'lon': 4.88969}}, {'city': 'Eindhoven', 'country': 'Netherlands', 'facility': 'Catharina ziekenhuis', 'geoPoint': {'lat': 51.44083, 'lon': 5.47778}}, {'city': 'Gouda', 'country': 'Netherlands', 'facility': 'Groene Hart Ziekenhuis', 'geoPoint': {'lat': 52.01667, 'lon': 4.70833}}, {'city': 'Leiden', 'country': 'Netherlands', 'facility': 'Diaconessenhuis Leiden', 'geoPoint': {'lat': 52.15833, 'lon': 4.49306}}, {'city': 'The Hague', 'country': 'Netherlands', 'facility': 'MC Haaglanden', 'geoPoint': {'lat': 52.07667, 'lon': 4.29861}}, {'city': 'Asker', 'country': 'Norway', 'facility': 'Vestre Viken HF, Sykehuset Asker og Baerum', 'geoPoint': {'lat': 59.83333, 'lon': 10.43721}}, {'city': 'Bergen', 'country': 'Norway', 'facility': 'Haukeland Universitetssykehus', 'geoPoint': {'lat': 60.39299, 'lon': 5.32415}}, {'city': 'Kristiansund', 'country': 'Norway', 'facility': 'Helse Nordmore og Romsdal HF, Kristiansund Sykehus', 'geoPoint': {'lat': 63.11045, 'lon': 7.72795}}, {'city': 'Oslo', 'country': 'Norway', 'facility': 'Olso Universitetssykehus HF, Radiumhospitalet', 'geoPoint': {'lat': 59.91273, 'lon': 10.74609}}, {'city': 'Oslo', 'country': 'Norway', 'facility': 'Oslo Universitetssykehus, Aker', 'geoPoint': {'lat': 59.91273, 'lon': 10.74609}}, {'city': 'Lisbon', 'country': 'Portugal', 'facility': 'Clinica de Santo Antonio', 'geoPoint': {'lat': 38.72509, 'lon': -9.1498}}, {'city': 'Lisbon', 'country': 'Portugal', 'facility': 'Hospital Militar', 'geoPoint': {'lat': 38.72509, 'lon': -9.1498}}, {'city': 'Lisbon', 'country': 'Portugal', 'facility': 'Hospital Santa Maria', 'geoPoint': {'lat': 38.72509, 'lon': -9.1498}}, {'city': 'Bošany', 'country': 'Slovakia', 'facility': 'VEBMED, s.r.o.', 'geoPoint': {'lat': 48.57883, 'lon': 18.24864}}, {'city': 'Bratislava', 'country': 'Slovakia', 'facility': 'CUIMED, s.r.o.', 'geoPoint': {'lat': 48.14816, 'lon': 17.10674}}, {'city': 'Bratislava', 'country': 'Slovakia', 'facility': 'Nemocnica Svateho Michala, a.s.', 'geoPoint': {'lat': 48.14816, 'lon': 17.10674}}, {'city': 'Bratislava', 'country': 'Slovakia', 'facility': 'Univerzitna nemocnica Bratislava', 'geoPoint': {'lat': 48.14816, 'lon': 17.10674}}, {'city': 'Bratislava', 'country': 'Slovakia', 'facility': 'URO clinic, s.r.o.', 'geoPoint': {'lat': 48.14816, 'lon': 17.10674}}, {'city': 'Galanta', 'country': 'Slovakia', 'facility': 'Poliklinika Galanta', 'geoPoint': {'lat': 48.19001, 'lon': 17.72747}}, {'city': 'Košice', 'country': 'Slovakia', 'facility': 'MEDICONA s.r.o.', 'geoPoint': {'lat': 48.71441, 'lon': 21.25802}}, {'city': 'Levice', 'country': 'Slovakia', 'facility': 'UROCENTRUM LEVICE, s.r.o.', 'geoPoint': {'lat': 48.21563, 'lon': 18.60705}}, {'city': 'Malacky', 'country': 'Slovakia', 'facility': 'Poliklinika Malacky', 'geoPoint': {'lat': 48.43604, 'lon': 17.02188}}, {'city': 'Martin', 'country': 'Slovakia', 'facility': 'Univerzitna nemocnica Martin', 'geoPoint': {'lat': 49.06651, 'lon': 18.92399}}, {'city': 'Nitra', 'country': 'Slovakia', 'facility': 'UROEXAM, spol. s r.o.', 'geoPoint': {'lat': 48.30763, 'lon': 18.08453}}, {'city': 'Považská Bystrica', 'country': 'Slovakia', 'facility': 'CENTRUM UROLOGIE Povazska Bystrica s.r.o', 'geoPoint': {'lat': 49.12153, 'lon': 18.42169}}, {'city': 'Prešov', 'country': 'Slovakia', 'facility': 'MILAB, s.r.o.', 'geoPoint': {'lat': 48.99923, 'lon': 21.2355}}, {'city': 'Skalica', 'country': 'Slovakia', 'facility': 'Nemocnica s poliklinikou Skalica, a.s.', 'geoPoint': {'lat': 48.8449, 'lon': 17.22635}}, {'city': 'Šaľa', 'country': 'Slovakia', 'facility': 'UROCENTRUM SALA, s.r.o.', 'geoPoint': {'lat': 48.15127, 'lon': 17.88062}}, {'city': 'Topoľčany', 'country': 'Slovakia', 'facility': 'M & M & M, s.r.o.', 'geoPoint': {'lat': 48.56361, 'lon': 18.16712}}, {'city': 'Trenčín', 'country': 'Slovakia', 'facility': 'PRIVATNA UROLOGICKA AMBULANCIA s.r.o.', 'geoPoint': {'lat': 48.89452, 'lon': 18.04436}}, {'city': 'Vráble', 'country': 'Slovakia', 'facility': 'UROREX, s.r.o.', 'geoPoint': {'lat': 48.24371, 'lon': 18.30846}}, {'city': 'Basel', 'country': 'Switzerland', 'facility': 'Universitätsspital Basel', 'geoPoint': {'lat': 47.55839, 'lon': 7.57327}}, {'city': 'Zurich', 'country': 'Switzerland', 'facility': 'Urozentrum Zürich', 'geoPoint': {'lat': 47.36667, 'lon': 8.55}}, {'city': 'London', 'country': 'United Kingdom', 'facility': 'Homerton University Hospital', 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}, {'city': 'London', 'country': 'United Kingdom', 'facility': 'Kings College Hospital', 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}, {'city': 'London', 'country': 'United Kingdom', 'facility': 'Royal Marsden Hospital', 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}, {'city': 'London', 'country': 'United Kingdom', 'facility': 'Whipps Cross Hospital', 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}, {'city': 'Redhill', 'country': 'United Kingdom', 'facility': 'East Surrey Hospital', 'geoPoint': {'lat': 51.24048, 'lon': -0.17044}}, {'city': 'Sunderland', 'country': 'United Kingdom', 'facility': 'Sunderland Royal Hospital', 'geoPoint': {'lat': 54.90465, 'lon': -1.38222}}], 'overallOfficials': [{'name': 'Global Clinical Compliance', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Ferring Pharmaceuticals'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Ferring Pharmaceuticals', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}